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1. INTRODUCTION 
 
1.1. Gross anatomy of the mammalian lung 
The lung is a complex and highly specialized multicellular organ which main function 
is the process of gas exchange to release carbon dioxide (CO2) and oxygenate the 
blood. Mouse models have shown to be relevant tools for a better understanding of 
the complicated cellular and molecular mechanisms underlying processes during 
lung homeostasis and disease. Nevertheless, the translation to humans involves 
thorough validation due to the explicit functional and physiological differences 
between species1. For instance, there are clear differences in respiratory frequency, 
total lung capacity, and tidal volume between mice and men. Additionally, the 
murine right lung is divided into four lobes - cranial, middle, caudal, and accessory - 
while the left lung has only one lobe. In contrast, the human right lung consists of 
three lobes: upper, middle, and lower, separated by the oblique and horizontal 
fissures, whereas the left lung is divided into upper and lower lobe by the oblique 
fissure1,2. 
 
Despite these differences, two comparable structural and functional compartments 
have been identified in the lower respiratory tract of both species: the conducting 
tract and the respiratory zone (Fig. 1-1). The conducting tract is comprised of the 
airways including the trachea, bronchi, and bronchioles which serve as air 
conducting structures. Beginning with the trachea, every conducting airway splits by 
bifurcation. In this process, the trachea subdivides into two main primary bronchi 
entering the left and right lung and continue to branch in a dichotomous (men) or 
monopodial (mice) pattern3. During dichotomous branching, the parental segment 
symmetrically divides giving rise to two smaller segments, whereas during 
asymmetrical monopodial branching, a larger parent segment progressively divides 
into smaller daughter segments. In both instances, continuous branching gives rise 
to the bronchial tree, which includes 17 to 21 and 13 to 17 airway generations in 
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men and mice, respectively. In men, cartilage rings are present in the intralobar 
bronchi but become continuously thinner with each division and slowly transition 
into bronchioles deprived of cartilage. In mice, this distinction between bronchi and 
bronchioles is not observed as cartilage rings are only present in the 
extrapulmonary airways1,2,4. Terminal bronchioles represent the most distal 
components of the conducting tract.  
 
The respiratory zone encompasses the respiratory bronchioles, alveolar ducts, and 
alveolar sacs, the latter representing the functional respiratory units of the lung. In 
contrast to humans, mice generally do not have respiratory bronchioles and 
consequently most of the terminal bronchioles directly proceed into alveolar ducts 
lined by alveoli. At the end of the respiratory zone, the alveoli cluster to form 
alveolar sacs with gas exchange occurring through capillaries carrying blood from 
other parts of the body1,2. The total number of alveoli has been estimated to be 
around 486 million (men) and 4.2 million (mice) per adult lung providing in humans 
a vast surface area of approx. 143 m2 for gas exchange5,6.  
 
Figure 1-1. Lower respiratory tract1. 
The lower respiratory tract includes 
the trachea, bronchi, bronchioles 
and alveoli. In the lung, each 
bronchus divides into bronchi and 
continues to branch into smaller 
airways (bronchioles). The 
bronchioles end in the alveoli which 
form alveolar sacs. Image 
reproduced from Frank Netter, Atlas 
of human anatomy, 4th Edition, page 
204 (2006).  
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1.2.  Cellular and molecular basis of lung development  
During development, the lung undergoes successive and morphologically distinct 
stages to achieve functionality. Lung development in mice begins at embryonic day 
(E) 9.5 (approx. day 28 in men) in the anterior foregut endoderm from where two 
primary buds arise8,9. In contrast, the trachea develops from a portion of the ventral 
foregut that separates from the dorsal portion, which will form the esophagus10. 
Human and murine lung development is divided into five overlapping stages based 
on sequential branching morphogenesis and mediated by signals coming from the 
surrounding mesenchyme: embryonic, pseudoglandular, canalicular, saccular, and 
alveolar (Fig. 1-2)11,12. Several mesenchymal signals regulate early embryonic cell 
fate decisions including the following signalling pathways: FGF, EGF, BMP, TGF-β, 
WNT, hedgehog, retinoic acid, and Notch11,13. The expression of these signals varies 
significantly along the proximal-distal axis; consequently, interference with any of 
these pathways severely impairs lung development processes, resulting in abnormal 
phenotypes14–16. 
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Figure 1-2. Embryonic, fetal, and postnatal development of the lung17. Lung development 
in mouse and human consists of five overlying stages: embryonic, pseudoglandular, 
canalicular, saccular, and alveolar. As branching progresses, epithelial progenitors give rise 
to epithelial cells with differentiated characteristics while gradually becoming more lineage 
restricted. FGF, Fibroblast growth factors; EGF, epidermal growth factor; TGF-β; 
transforming growth factor-beta; BMP, bone morphogenic protein; HH, hedgehog; RA, 
retinoic acid. Image reproduced from Rackley, C. R. et al. J. Clin. Invest. 122, 2724–30 
(2012). 
 
At the embryonic stage, the endoderm undertakes progressive cell fate decisions 
giving rise to epithelial progenitor cells with progressive lineage restriction. The 
exact timing for epithelial progenitor cell appearance is highly dependent on the 
region and cell type. During this period, local expression of the transcription factor 
Nkx2.1 is an early indicator of lung specification marking the ventral boundary in the 
anterior foregut where the trachea and primary lung buds appear9,18,19. Then, lung 
buds undergo several rounds of elongation and branching in a highly fixed pattern, 
creating a complex tree-like structure20. Interestingly, FGF10-deficient mice exhibit a 
severe main stem bronchi formation defect3,21. These data suggest that branching 
morphogenesis considerably relies on the local expression of FGF10 by the 
mesenchyme and its receptor expression, FGFR2, in the endoderm.  
 
During the pseudoglandular stage, epithelial cells undergo proximal-to-distal 
differentiation. For instance, differentiated Foxj1-expressing ciliated cells and 
pulmonary neuroendocrine cells appear first in the proximal conducting airways and 
are found subsequently in distal regions of the airways22,23. Moreover, while 
expression of the transcription factor SOX2 characterizes proximal progenitors that 
differentiate into neuroendocrine, secretory, ciliated, and mucosal cells, distal 
progenitors located in the tips of the expanding tubes are defined by expression of 
SOX9 and ID224,25.  
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The following canalicular phase is characterized by additional peripheral branching, 
branch elongation and widening of distal airspaces12. Notably, capillaries begin to 
assemble around the airspaces and their contact with the overlying cuboidal 
epithelium induces epithelial flattening, providing the basis for formation of the first 
primitive air-blood barriers. Expression of secretoglobin 1A1 (SCGB1A1), a marker 
for secretory club cells, starts in the canalicular stage but functional club cells 
capable of protein secretion do not appear until the postnatal stage22.  
 
As lung development continues, the acinar epithelium begins its differentiation into 
alveolar epithelial type I cells (AECI), and the surfactant-producing type II cells 
(AECII)26,27. In the beginning of the saccular stage, airways end in large 
smooth-walled cylindrical structures, termed terminal saccules, which become more 
complex as gestational age progresses with continuous distal growth and 
subdivisions of airspaces. Finally, during the alveolar period, final maturation of the 
lung is achieved with most of the alveoli established and gas exchange surface area 
vastly increasing due to secondary septation. Alveolarization starts before birth in 
humans while, in mice, this process occurs exclusively postnatally28,29. Of note, basal 
and mucous cells emerge last during development and generally appear just prior to 
birth30. 
 
1.3. Cellular composition of the respiratory epithelium  
The adult lung is an extremely intricate organ comprised of over 40 different unique 
cell types which provide multiple region-specific functions including formation of a 
physical barrier against inhaled pathogens, synthesis of host-defense compounds 
such as antimicrobial proteins and mucins, removal of pathogens and particles 
through mucociliary clearance, crosstalk with immune cells by cytokine and 
chemokine release, establishment of a thin air-blood interface to enable gas 
exchange, and production and secretion of pulmonary surfactant to reduce alveolar 
surface tension9,31.  
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To achieve these and other crucial functions, the cellular composition of the lung 
epithelium varies along its proximal to distal axis (Fig. 1-3). In the lower respiratory 
tract of mice, the trachea, the two main bronchi, and the upper regions of the 
intralobar airways are lined by pseudostratiﬁed columnar epithelium comprised of 
club, ciliated, pulmonary neuroendocrine cells, and basal cells, interspersed by 
submucosal glands underneath the airway epithelium surface32,33. A major function 
of the secretory cells of the lower respiratory tract is the establishment of a 
defensive mucous layer on the epithelial cell surface to confine inhaled pathogens. 
In contrast to humans, goblet cells are scarce in the pseudostratiﬁed columnar 
epithelium of mice4,34. Also in humans, basal cell numbers gradually decrease 
towards the distal part of the bronchiolar tree whereas murine simple columnar 
epithelium in the intralobar bronchioles is already deprived of basal cells17.  
 
Figure 1-3. Cell components of the murine respiratory system35. (a) Tracheobronchial 
airways are formed by pseudostratified epithelium harbouring basal, ciliated, and secretory 
club cells. (b) Intralobar bronchioles are lined by a simple columnar epithelium containing 
ciliated and club cells. (c) The alveoli are lined by squamous AECI and cuboidal AECII. 
SFTPC+SCGB1A1+ bronchioalveolar stem cells are present in the bronchoalveolar duct 
junction and alveoli. AEC are closely associated with mesenchymal cells such as fibroblasts 
and endothelial cells. Image reproduced from Rock, J. R. & Hogan, B. L. M. et al. Annu. Rev. 
Cell Dev. Biol. 27, 493–512 (2011). 
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As described before, the trachea bifurcates into two main bronchi which 
subsequently subdivide into smaller bronchioles. At this point, the epithelium 
gradually turns into a simple columnar epithelium containing ciliated and secretory 
cells (club and globet cells) which drive removal of inhaled microorganisms and 
particulates by mucociliary clearance35–37. In contrast with the scarce pulmonary 
neuroendocrine cells found in the proximal airways, pulmonary neuroendocrine 
cells in the intralobar airways aggregate in structures termed neuroepithelial 
bodies. Pulmonary neuroendocrine cells are in contact with sensory nerve fibres 
and are thought to react to stimuli such as hypoxia and release bioactive substances 
(e.g. serotonin, calcitonin, and bombesin) which may in part regulate the immune 
response of epithelial cells, flow of air and blood, lung growth and development32,34.  
 
In the terminal bronchioles, the columnar epithelium is replaced by alveoli 
comprised of flat squamous AECI and cuboidal AECII. AECI account for about 95% of 
the total surface area of the lung however only represent a minor fraction of the 
total cell number in the alveoli due to their flattened squamous shape38. AECI are 
the prime sites for gas exchange and regulate fluid clearance39. Of note, AECII 
secrete pulmonary surfactant, a complex mixture of lipids, such as 
phosphatidylcholine and neutral lipids, and associated proteins: surfactant protein 
A, B, C, and D. Pulmonary surfactant is stored inside intracellular organelles, called 
lamellar bodies, and plays a critical role in reducing alveolar surface tension to 
prevent alveolar collapse at low pressures and providing host defense by binding of 
surfactant collectins to the surface of microbes which causes microbe aggregation,  
thereby enhancing pathogen uptake and killing by alveolar macrophages40,41. 
 
Besides the epithelium, the lung contains other cell types such as endothelium of 
veins, arteries, capillaries, and lymphatic vessels as well as pericytes, fibroblasts, 
vascular and airway smooth muscle cells, myofibroblasts, lipocytes, and 
mesothelium. These cells interact directly with the respiratory epithelium 
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modulating lung development, homeostasis, and repair9,42–46. For instance, epithelial 
platelet-derived growth factor α is required for the recruitment of smooth muscle 
cell progenitors to the distal tips of the airways, where they differentiate and 
deposit elastin to promote alveolarization44. 
 
1.4. Lung injury and regeneration 
1.4.1. Epithelial progenitor/stem cells in the adult lung 
Despite the slow epithelial turnover in the lung under homeostatic conditions, 
numerous studies have shown that to regain lung homeostasis and functionality 
following injury, region-specific epithelial stem/progenitor populations that reside in 
niches along the proximal-distal axis of the respiratory tree become activated and 
exhibit a remarkable capacity to self-renew, proliferate and differentiate into more 
specialized cells to restore the respiratory epithelium (Fig.1-4)31,47–51.  
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Figure 1-4. Stem/progenitor cells in the adult mouse lung47. Location, distribution, and 
differentiation of potential lung epithelial stem/progenitor cells along the proximal-distal 
axis of the respiratory epithelium. SMG, airway submucosal gland; NEB, neuroepithelial 
bodies; BADJ, bronchoalveolar duct junction; BASC, bronchioalveolar stem cells; PNEC, 
pulmonary neuroendocrine cells. Image reproduced from Li, F., He, J., et al. Stem Cells Int. 
2015, 1–11 (2015). 
 
Multiple stem/progenitor cell populations in the lung with different extent of 
plasticity or lineage commitment have been recently identified, and we have just 
begun to understand their lineage relations, differentiation potential, and their 
capacity to contribute to lung repair after injury. During normal turnover and upon 
injury, a subset of basal cells in the trachea and main stem bronchi has been 
described as the dominant epithelial stem cell type responsible for the regeneration 
of all main epithelial cell types in the pseudostratified epithelium including ciliated, 
goblet, and club cells52–54. Basal stem cells are characterized by expression of the 
cellular surface markers transcription factor transformation-related protein 63 
(P63), cytokeratin 5 (KRT5), cytokeratin 14 (KRT14), and Aquaporin 3 (AQP3). This 
has been demonstrated by lineage tracing approaches with KRT5-CreERT2 mice in 
which  KRT5- expressing basal cells could differentiate into club and ciliated cells 
during both steady state and repair4. Accordingly, nerve growth factor receptor 
(NGFR) and integrin alpha 6 (itgα6) were identified as potential cellular markers for 
the isolation of human basal cells with stem cell properties48. Additionally, a 
region-specific itgα6brightSca-1 (stem cells antigen-1)+ALDH1 (aldehyde 
dehydrogenase-1)+ basal cell subset showed self-renewal potential in vitro and 
participated in epithelial maintenance of the airways and in injury repair upon 
naphthalene treatment in vivo53. Besides basal cells, submucosal glands found in the 
trachea contain a fairly uncharacterized stem/progenitor cell population which has 
the ability to regenerate not only submucosal glands tubules and ducts but also the 
surrounding epithelium50,55. Also, along the proximal-distal axis of the airways, 
secretory club cells display progenitor potential by providing not only long-term 
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maintenance but also by contributing to bronchiolar epithelium renewal after 
injury37. Notably, lineage-tracing with SCGB1A1-CreERTM mice during homeostasis 
proved that SCGB1A1-expressing secretory club cells give rise to ciliated cells, 
although the contribution of club cells to basal cell regeneration was relatively low. 
Nevertheless, after ablation of KRT5+ cells, a fraction of SCGB1A1-positive secretory 
cells dedifferentiate into basal-like stem cells with self-renewal and differentiation 
properties56. 
 
Numerous studies have recognized another subpopulation of SCGB1A1+ cells, 
termed variant club (vClub) cells, which are resistant to toxic agents, lack 
CyP450-2F2  ̶  a relevant xenobiotic-metabolizing enzyme  ̶  and show stem cell 
properties including the capacity for self-renewal and contribute to club and ciliated 
cell replenishment49,57,58. Besides the bronchial airways, vClub cells located at the 
bronchoalveolar duct junction of the distal bronchioles were shown to restore the 
airway epithelium following depletion of club cells by naphthalene in vivo59.  
 
Other bronchiolar progenitors include cell subsets that are enriched by flow 
cytometry based on their differential cell surface expression of EpCAM and Sca-1, 
and their autofluorescence (AF) characteristics. In response to naphthalene, a 
CD45−CD31−CD34−EpCAM+Sca-1lowAFlow cell population was resistant and highly 
proliferative while CD45−CD31−CD34−EpCAM+Sca-1lowAFhigh cells were described as 
regular naphthalene-sensitive club cells60. In a similar study, epithelial progenitors 
isolated by FACS based on EpCAMhiitgα6 integrin beta (itgβ)4+CD24low marker 
expression exhibited self-renewal potential and gave rise to both airway and 
alveolar cell lineages in vitro61. Following severe H1N1 influenza infection, two rare 
epithelial stem/progenitor cells of the distal airways, lineage-negative epithelial 
stem/progenitors (LNEP) and distal airway stem cells (DASC), become activated and 
migrate to the sites of injury within alveoli to support lung repair. LNEP are defined 
by the surface marker signature itgβ4+CD200+CD14+ whereas DASC co-express P63 
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and KRT5. Transplantation of LNEP and DASC into influenza-infected mice, not only 
showed a substantial engraftment of these stem cells into the injured lungs but also 
differentiated into bronchiolar and alveolar epithelial cell lineages62–65.  
 
At the bronchioalveolar duct junction (BADJ), the bronchioalveolar stem cells (BASC) 
represent another important stem/progenitor cell population which co-express 
SCGB1A1 and surfactant protein C (SFTPC) and can differentiate into club cells, 
AECII, and AECI in vitro51,59. For instance, BASC were able to regenerate the 
respiratory epithelium following lung injury induced by exposure to influenza virus, 
naphthalene, and bleomycin66,67. Diverse cell surface markers have been identified 
for the isolation and identification of BASC including Sca-1, CD24, and itgα6β451,60,68–
72. Moreover, BASC were also enriched in a EpCAM+Sca-1lowCD24low cell 
subpopulation70. In line, a distal epithelial stem/progenitor cell fraction 
(EpCAM+Sca-1lowitgα6β4+CD24low) was found capable of self-renewal and gave rise 
to airway and alveolar epithelial cells71.  
 
In the alveoli, a subpopulation of AECII have been referred to as stem/progenitor 
cells for squamous AECI in the adult lung by in vitro cell proliferation and clonogenic 
assays, in vivo epithelial injury repair, and lineage tracing analysis4,73–77. In addition, 
expression of itgα6β4 might represent a potential biomarker for stem/progenitor 
cells since an AECII subset containing SFTPC-itgα6β4+ cells was discovered in the 
alveolar epithelium and contributed to AECI generation in the alveoli ex vivo78. 
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Table 1-1. Putative stem/progenitor cell populations of the adult murine lung 
epithelium31. Markers used to define the different stem/progenitor cells along the 
proximal-distal axis of the murine lung. LNEP, lineage-negative epithelial stem/progenitors; 
DASC, distal airway stem cells; BASC, bronchioalveolar stem cells. Modified from Kotton, D. 
N. & Morrisey, E. E. et al. Nat Med 20, 822–832 (2014). 
 
Although less well-characterized, several cellular markers have been identified for 
the isolation of human lung stem cells including AQP3, c-kit, NGFR, itgα6, Lgr6, 
HTII-280, ICAM-14,48,50,52,73,79–81. For instance, a subset of basal cells and AECII 
isolated by FACS analysis of NGFR/itgα6 and HTII-280 expression, respectively, were 
identified as potential human lung stem cells48,73. Similarly, c-kit+ cells and 
E-Cad/Lgr6+ cells were recognized as human stem cells due to their capacity for 
self-renewal and differentiation in vitro and in vivo80,82. However, mainly due to lack 
of lineage tracing methodologies in the human system, none of these markers were 
found to robustly define a human lung stem cell giving rise to differentiated 
epithelial cells in the human lung. 
 
Stem/progenitor cell Marker expression 
Basal cells P63, KRT5, KRT14, NGFR, AQP3 
Duct cells KRT5, KRT14, KRT18 
Club cells SCGB1A1, CYP2F2hi 
vClub cells SCGB1A1, CYP2F2- 
Bronchiolar progenitors EpCAM+Sca-1lowAFlow 
Multipotent epithelial progenitors EpCAMhiitgα6β4+CD24low 
LNEP itgβ4, CD200, CD14, ΔNp63 
DASC P63, KRT5, KRT6 
BASC SCGB1A1, SFTPC, Sca-1, CD34 
integrinα6β4 progenitors itgα6, itgβ4 
AECII SFTPC 
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Overall, the identification of several self-renewing stem/progenitor cell populations 
highlights the complexity of the cellular networks involved in lung epithelial repair. 
For instance, distinct stem/progenitor cell population(s) are activated upon 
regenerative signals depending on the injury type, severity, and affected region 
(Table 1-1). Nonetheless, some of the characterized stem/progenitor candidates 
may at least to some extent represent the same cell types, phenotypic variants or 
subpopulations of a single cell population. For example, this could be the case for 
the LNEP and DASC that arise upon influenza infection, and BADJ-associated vClub 
cells and BASC that endure naphthalene injury. 
 
1.4.2. Epithelial progenitor/stem cells niches in the adult lung 
Stem cell niches refer to local tissue-specific microenvironments that maintain or 
activate stem cells during homeostasis or upon injury, respectively. Distinct stem 
cell niches have been discovered in the adult lung providing signals for 
maintenance, proliferation, and differentiation of epithelial progenitor/stem cells83. 
As described by our laboratory and others, FGF10 has recently been suggested to 
play a dominant role in the crosstalk between mesenchymal and epithelial cells in 
the developing lung and in response to injury84,85. Communication among lung stem 
cells and their niches yields an effective system vital for retaining stem cell potential 
that contributes to cell fate and migration decisions33,55,86. Through multiple murine 
injury models and lineage tracing approaches, six putative stem cell niches have 
been identified in the adult lung including the duct of submucosal glands, surface 
basal cells in the intercartilaginous zone underlying the proximal airways4,48,87, 
neuroepithelial bodies residing in the bronchi and bronchioles57,76,86,88, BADJ 
regions51,59,60,68,70, and the alveolar epithelium73,77,89. 
 
Numerous data have demonstrated that BADJ is the stem cell niche for BASC, which 
are capable to regenerate both airway and alveoli lineages after injury. During 
lineage tracing analysis with SCGB1A1-reporter mice, SCGB1A1-labeled cells failed 
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to promote alveolar repair following hyperoxia-induced lung injury49. Nonetheless, 
upon murine lung injury with influenza virus infection, naphthalene, or bleomycin 
exposure, BASC were capable of self-renewal and repair of the epithelium in vivo 
and gave rise to club cells and AEC ex vivo66,67. These studies suggest that the 
potential of BASC to regenerate injured respiratory epithelium might be injury-
specific and rely on distinct microenvironmental cues at BADJ.  
 
At the end of the respiratory tree, AECII have been proposed as the major 
stem/progenitor cells responsible for self-renewal and regeneration of AECI 
following injury although AECII are not capable to give rise to other distal or 
proximal cells4,73–77. It has been suggested that primary platelet-derived growth 
factor receptor alpha+ (PDGFRα) lung resident cells include a population of 
lipofibroblasts which reside in close proximity to AECII. Lipofibroblasts may play a 
significant role in epithelial-mesenchymal crosstalk during alveolar development 
and serve as a stem cell niche in the lung73,90. 
 
1.4.3. Role of tissue-resident alveolar macrophages during lung development and 
repair  
Two major classes of lung macrophages have been recognized, tissue resident 
alveolar macrophages (TR-Mac) and interstitial macrophages. During 
embryogenesis, fetal TR-Mac F4/80intCD11bhiLy6c+ derived from embryonic 
progenitors coming from the yolk sac reach the developing lung at E10.591–94. 
Despite the dogma that tissue macrophages constitutively derive from monocytes, 
recent publications using monocyte fate mapping, parabiosis, and adoptive transfer 
strategies have shown that, tissue macrophages, including TR-Mac, are capable to 
proliferate and self-renew independently of circulating monocytes95–97. 
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Due to the localization in the alveolar lumen, TR-Mac are the first line of defense 
against air-borne pathogens including bacteria, fungi, and viruses mainly by 
clearance through phagocytosis of infected cells98–102. Besides phagocytosis of 
foreign particles, TR-Mac are also essential for surfactant catabolism. In this regard, 
the growth factor GM-CSF (granulocyte-macrophage colony stimulating factor) has 
been shown to be vital for TR-Mac maturation through activation of the nuclear 
receptor PPAR-γ which also drives cholesterol metabolism, β-oxidation of fatty 
acids, lipid transport, storage and degradation103. 
 
1.4.4. Growth factors driving lung generation and regeneration 
Growth factors are small proteins that diffuse through short distances and induce 
diverse cellular responses through activation of different signaling pathways. During 
lung development, growth factors such as FGF1021, VEGF104, PDGF105, and TGFβ106 
play a crucial role in branching morphogenesis, cell proliferation and differentiation. 
Furthermore, after lung injury, growth factor responses activate repair mechanisms 
aimed to restore lung homeostasis107,108. For instance, hyperoxia-induced injury in 
mice increases FGF7 and FGF2 levels in the lung, promoting AECII proliferation and 
enabling repair of the damaged epithelium108. 
 
As mentioned in the previous section, GM-CSF is a growth factor essential for 
differentiation and function of myeloid cells. In the lung, GM-CSF is involved in 
several cell functions including antiviral and antimicrobial responses, and surfactant 
metabolism109–111. Besides being produced by myeloid cells, GM-CSF is highly 
released by AECII under inflammatory conditions112. Moreover, after viral infection, 
AEC-derived GM-CSF has been shown to promote epithelial repair and restoration 
of barrier function by proliferation of AECII113. Based on these observations, it is of 
great interest to investigate the role of GM-CSF on proliferation and differentiation 
of distal lung stem/progenitor cell populations during lung homeostasis and after 
injury. 
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1.4.5. Lung organoid systems to model lung development and disease  
Modern technology has led to the identification and characterization of several 
stem/progenitor cells crucial for organ development and regeneration in mammals. 
Nonetheless, several cellular and molecular processes can not be easily studied in 
vivo and traditional 2D in vitro cultures lack the conditions necessary to study 
distinct features involved in organ formation and regeneration, such as intercellular 
crosstalk and cell polarization. Consequently, three-dimensional (3D) culture 
systems have recently emerged as a valuable platform for the better understanding 
of organogenesis and disease processes in vitro114. The term “organoids” refers to 
3D structures derived from single stem cells which differentiate into organ-specific 
cells types that self-organize to form a structure resembling the cellular organization 
and functionality of the organ of origin115. Notably, these systems can be used to 
study embryonic developmental mechanisms, model tissue during homeostasis and 
disease, and define and characterize stem cell-niche interactions116,117.  
 
Organoids can originate from three main stem cell sources: embryonic stem cells, 
induced pluripotent stem cells (iPSC) and adult somatic stem cells115,118. Using 
different protocols it is now possible to produce tissue-specific organoids derived 
from human and/or murine mammary gland119, bone120, small intestine121,122, 
stomach123,124, colon125, liver126,127, pancreas128, retina129, brain130, thyroid131, 
heart132, prostate133, and lung48,73,134,135. Therefore, 3D organoid models have 
recently developed as a powerful technology for in vitro modeling of development 
and disease, as well as for drug discovery136,137.  
 
Regarding the lung, organoid models have been developed to visualize and study 
processes of generation and regeneration of the lung with the future vision to 
translate the knowledge gained from these models into therapeutic strategies. 
Some of the adult epithelial progenitor/stem cells described in section 1.4.1 can 
generate organoids which partially reproduce the complexity of lung structures 
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when cultured in an appropriate microenvironment (Fig. 1-5). One crucial 
requirement for 3D organoid formation and cell differentiation is the use of 
hydrogels, such as Matrigel, which contain a mixture of extracellular matrix 
components138. Such extracellular matrix in combination with air-liquid interface 
culture systems have been shown to boost lung organoid growth, polarization and 
cell differentiation48,139,140. To date, lung organoids are generated in 3D cultures 
from single stem/progenitor cells by addition of growth factors such as EGF and 
retinoic acid, or by co-cultivation with feeder cells including fibroblasts, endothelial 
cells, or smooth muscle cells (Table 1-2)48,73,134,135. 
 
 
Figure 1-5. Murine lung organoid models141. Lung organoids generated from epithelial cells 
isolated from different respiratory compartments. P63+ basal cells are capable of giving rise 
to trachea/bronchospheres, AECII form alveolospheres while SCGB1A1+SFTPC+ BASC 
generate bronchiolar organoids, bronchioalveolar organoids, and alveolospheres. Image 
modified from Nadkarni, R. R., Abed, S. & Draper, J. S. et al. Biochem. Biophys. Res. 
Commun. 473, 675–682 (2016). 
 
For instance, isolated murine basal cells expressing P63 and NGFR generate 
organoids termed tracheospheres. After 14 days of culture, these spherical 
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organoids consist of a P63+KRT5+KRT14+NGFR+ basal cell layer enclosed by another 
layer of KRT8+ differentiated goblet and ciliated cells on the luminal side48,142. Due to 
its close resemblance with the cell composition of the proximal airways, 
tracheospheres have been proposed as models for the screening of new drugs and 
small molecules aimed to treat lung diseases, such as asthma and CF which are 
associated with inflammation, cellular stress, and a significant increase of secretory 
cells at the expense of ciliated cells35. Using clonal tracheosphere assays derived 
from Foxj1-GFP transgenic mice in combination with in vivo approaches, Tadokoro 
and colleges found that an increase in IL-6/STAT3 signaling favors basal cell 
differentiation into ciliated cells rather than secretory cells54. In similar studies, 
treatment with BMP signalling pathway inhibitors led to higher cell proliferation and 
colony formation efficiency but prevented basal cell differentiation143,144.  
 
Human basal cells also form organoids named tracheospheres, bronchospheres or 
nasospheres depending on whether the basal cells are derived from the trachea, 
large airways or nasal epithelium, respectively. As in murine tracheospheres, these 
organoids contained P63+KRT5+ basal cells and functional ciliated and goblet cells145–
147. In this regard, screening of 5000 different compounds in human bronchospheres 
identified Notch signaling pathway as a possible regulator of basal cell 
differentiation. For instance, inhibition of NOTCH1 receptor let to a significant 
increase in the expression of basal cell markers whereas blocking of NOTCH2 
receptor enabled the expression of ciliated markers instead of goblet cell 
markers146. These data not only supported previous observations depicting Notch as 
a relevant regulator of secretory and ciliated cell differentiation in vivo148,149 but also 
brought novel information on Notch signaling activation. In addition, using air-liquid 
interface and organoid cultures, Gao and colleagues identified through CRISPR/Cas9 
genome editing of primary human basal cells the role of transcription factor 
grainyhead-like 2 in regulating barrier function and differentiation of ciliated cells 
150. 
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In diverse studies, secretory club cells capable of forming organoids were isolated 
by flow cytometry based on the expression of surface cell markers. McQualter and 
colleagues used the expression signature EpCAMhiitgα6β4+CD24low for stem cell 
isolation and when co-cultured with primary EpCAM-Sca1+ lung stromal cells 
obtained three distinct types of organoids61.  After 14 days in culture, 46% of the 
organoids were large and spheric with a single lumen (type A), 35% were small, 
dense, and lobular (type C) while 19% had a mixed phenotype, with multiple 
bud-like protrusions (type B). Type A and B organospheres comprised P63+ basal 
cells, Foxj1+ ciliated cells, and Muc5ac+ goblet cells while these markers were absent 
in type C colonies. In contrast, type C organospheres contained primarily SFTPC+ 
AECII-like cells whereas in type B colonies SFTPC+ AECII were only located at the tips 
of the buds. Comparable data in which epithelial colonies exhibited three distinct 
morphologies was observed when SCGB1A1-CreER lineage traced murine cells were 
co-cultivated with a mouse lung stromal cell line and a TGFβ inhibitor151.  
 
Similarly, Kim and colleagues characterized a 3D co-culture model of BASC and a 
heterogeneous population of lung endothelial cells which gave rise to three 
different kinds of organoid structures defined according to the expression of 
SCGB1A1 (bronchiolar), SFTPC (alveolar), or both (bronchioalveolar)152,153.  In this 
study, the 3D model was used to assess the role of the endothelial-derived 
BMP4-NFATc1-thrombospondin-1 signalling axis in BASC proliferation. The results 
indicate the potential of BASC to give rise to both alveolar and airway lineages and 
suggests that the alveolar differentiation can be augmented by thrombospondin-1 
released by endothelial cells134. 
 
Alveolospheres are generated by co-cultivation of lung stromal cells with AECII 
isolated from lineage traced-SFTPC+ cells or based on AECII surface markers. After 14 
days of culture, alveolospheres were composed of two cell levels, an outer layer  
containing SFTPC+ AECII and an internal layer comprised of AECI expressing the 
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differentiation markers Ager+, PDPN+, and Hopx+73,154. In human lungs, AECII are 
defined based on the cell surface expression of EpCAM+HTII-280+155. Nevertheless, 
alveolospheres do not recapitulate the structural features of the alveolar 
compartment in the adult lung and neither mouse nor human AECII can be 
expanded efficiently in culture before seeding in Matrigel.  
 
Human pluripotent stem cells (hPSC) can be obtained from human embryonic stem 
cells and induced pluripotent stem cells (hiPSC) and are able to self-renew 
indefinitely in culture while retaining the capacity to differentiate into almost any 
mature cell type in the human body156,157. For instance, hiPSC can be reprogrammed 
into adult somatic cells by addition of stage-specific growth factors to recapitulate 
signaling pathways involved in lung development9,158. Therefore, hiPSC-derived lung 
organoids may represent an attractive path for disease modeling. Such an organoid 
model could be used for drug screening of samples from patients with chronic 
asthma or CF to assess if epigenetic changes in the progenitors cells alters 
self-renewal and differentiation functions159–161. In this line, following step by step 
differentiation protocols, it has been possible to redirect murine and human PSC 
into lung progenitors159,162,163, mature airway and alveolar cells164, and to form an 
organized airway epithelium161,165–167. The most effective protocols first generate 
definitive endoderm, then anterior foregut endoderm, followed by ventral anterior 
foregut endoderm and NKX2.1+ lung progenitors168. Regarding human embryonic 
stem cells, the pseudoglandular or canalicular phase of the developing lung has 
been shown to be the best source of progenitors with the potential to give rise to 
airway and alveolar cell lineages169,170. 
 
So far, only a few studies have described the generation of lung organoids derived 
from hPSC in vitro. For example, hPSC-derived lung organoids were developed using 
a Matrigel-coated scaffold and were then transplanted into mice to achieve further 
airway differentiaiton171. Yet, this approach failed to generate alveolar cells implying 
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the need for more cell-specific protocols. In another study, Carboxypeptidase M 
(CPM) was identified as a cell-surface marker for ventral anterior foregut endoderm 
that overlapped with NKX2.1 expression. 3D culture of CPM-expressing cells with 
alveolar-associated growth factors and human lung fibroblasts gave rise to alveolar 
epithelial organospheres comprised of NKX2.1 and CPM-expressing cells, along with 
differentiated cells such as AQP5+ AECI and SFTPC+ AECII172. Such alveolar 
organospheres were comparable in structure and cell composition to 
alveolospheres generated from AECII in the adult murine lung73. In addition, Dye et 
al provided a protocol for hPSCs differentiation into multi-lineage organoids 
consisting of epithelial and mesenchymal compartments135. In this approach, the 
authors at first followed previous protocols to form organospheres. At this point, 
the hedgehog signaling pathway was stimulated to enhance NKX2.1 expression 
allowing organospheres to form complex structures termed human lung organoids 
(HLO)135. HLO developed proximal airway-like epithelial tubules harboring several 
cell types found in the airways such as basal, ciliated, and club cells. Even though 
HLO contained distal-like epithelial cells that co-expressed SFTPC/SOX9 and 
Hopx/SOX9, this model did not generate differentiated AEC. 
 
Lung organoid 
model 
Cell composition 
or markers 
Main organoid- 
forming cell type 
Feeder cell 
types 
Tracheo/broncho-
spheres 
Basal, ciliated,  
and goblet cells 
Basal cells HLF, HUVEC 
Bronchiolar 
organoids 
Club, ciliated  
and goblet cells 
BASC LuMEC 
Bronchioalveolar 
organoids 
Club, ciliated, goblet, 
AECI, and AECII  
 
BASC 
HLF, HUVEC, 
LuMEC 
Alveolospheres AECI and AECII  AECII, BASC 
PDGFRα+ lung 
stromal cells, 
LuMEC 
Alveolar 
organospheres 
AECI and AECII  
NKK2.1+SFTPC+CPM+ 
alveolar progenitors 
HLF 
HLO 
NKK2.1, SOX2, SOX9, 
P63, SCGB1A1, Muc5ac 
Hopx, ECAD, VIM, αSMA 
NKK2.1+FOXA2+ CPM+ 
lung progenitors 
hPSC-derived 
fibroblasts 
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Table 1-2. Properties of known lung organoid models141. Lung organoids derived from 
primary cells and hPSC, organoid cell composition and feeder cells. HUVEC, human 
umbilical vein endothelial cells; HLF, human lung fibroblasts; LuMEC, primary mouse lung 
endothelial cells; VIM, vimentin; ECAD, E-Cadherin; CPM, carboxypeptidase M. Modified 
from Nadkarni, R. R., Abed, S. and Draper, J. S. et al. Biochem. Biophys. Res. Commun. 473, 
675-682 (2016). 
 
Even with the significant advances in 3D culture technology, none of the models 
formerly described in this chapter recapitulates the structural complexity of the 
distal lung. Current lung organoid models mostly consist of only epithelial cells, and 
in rare cases, the mesenchymal compartment. In addition, tissue-resident cells of 
myeloid origin, which are important mediators of lung development, immune 
response and tissue regeneration, remain absent. 
 
In this line, epithelial stem/progenitor cells of the distal lung (EpiSPC) with a high 
proliferative response to influenza A virus (IAV)-induced lung injury have been 
recently described by our group85. Notably, EpiSPC have the capacity to self-renew 
and form organoids in Matrigel cultures in the presence of FGF10 and HGF. 
Following orthotopic transplantation into IAV-injured murine lungs, EpiSPC 
regenerate the distal lung tissue and give rise to AECI, thus demonstrating inherent 
stem cell properties. Hence, establishment of a lung organoid model that combines 
EpiSPC and mesenchymal cells to best represent the structural and cellular 
composition of the distal lung was envisioned. 
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Aims of the work 
2. AIMS OF THE WORK 
 
3D organoids currently reported in the literature only recapitulate certain 
morphological and cellular features of the lung. A model that fully recapitulates the 
complexity of the proximal and distal compartments of the lung is critically missing.  
 
Therefore, the aims of the present work were: 
1. Establishment of a robust protocol for the isolation and 3D co-culture of EpiSPC 
and lung-resident mesenchymal cells (rMC) to generate lung organoids 
comprised of well-organized tubular and saccular structures representing the 3D 
organization of the airways and alveoli, respectively. 
2. Successful integration of tissue-resident yolk-sack derived macrophages into the 
forming lung organoids to complement the system with further relevant 
lung-resident cell types and allow the study of intercellular cross-talk 
mechanisms, particularly those driving lung development and repair in vivo. 
3. Test the applicability of the in vitro system to study lung development by using 
lung organoids derived from BASC and rMC isolated from transgenic animals as 
well as morpholino addition to inhibit the activity of an important mRNAs or 
microRNAs involved in the regulation of lung generation. 
4. Investigate the impact of growth factors such as GM-CSF on stem/progenitor cell 
proliferation and differentiation during co-culture conditions to assess key 
factors known to be involved in alveolar repair following pathogen-induced lung 
injury and visualize the influence on distinct stages of lung organoid formation. 
5. Effective infection of lung organoids with IAV to further study and visualize 
processes of lung infection, injury and repair at high resolution and at a single-
cell level.  
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3. METHODS 
3.1. Mice strains 
Wildtype (WT) C57BL/6 mice were purchased from Charles River Laboratories. 
B6.129 [Cg)-Gt(ROSA)26Sortm4(ACTB-tdtomato-EGFP)Luo/J] (mTmG) mice, GM-CSF deficient 
(GM-CSF-/-) [B6.129S-Csf2tm1Mlg/J] mice and GM-CSF receptor β-deficient 
(GM-CSFRβ-/-) [B6.129S1-Csf2rbtm1Cgb/J] mice were obtained from Jackson 
Laboratory. Transgenic mice overexpressing GM-CSF (SPC-GM) in AECII were 
generated in GM-CSF deficient mice by expression of a chimeric gene containing 
GM-CSF under control of the human SP-C promoter and were a gift from Dr. Jeffrey 
Whitsett (University of Cincinnati, OH). Ai9 [B6.Cg-Gt(ROSA)26Sortm9(CAG-tdtomato)Hze/J] 
(mT) mice expressing tdTomato after Cre-mediated recombination, PDGFRαEGFP 
[B6.129S4-Pdgfra tm11(EGFP)So/J] expressing eGFP from the endogenous 
Pdgfra  locus (PDGFRαGFP), and TOPGAL [Tg(TCF/Lef1-lacZ)34Efu/J] reporter 
mice were provided by S. Bellusci (ECCPS, University of Giessen, Giessen, Germany). 
SCGB1A1mCherrySFTPCYFP reporter mice [B6;129-Sftpctm1.1(2A-YFP-2A-tTA-
N)ThbrScgb1a1tm1.1(2A-mCherry-2A-tTA-C)Thbr] were generated by T. Braun (Max Planck 
Institute for Heart and Lung Research, Bad Nauheim, Germany). Mice were housed 
under pathogen-free conditions.   
 
3.2. Model establishment  
3.2.1. Primary murine AEC isolation 
Primary murine lung cell isolation was modified from Herold, S. et al173. Mice were 
anesthetized with isoflurane inhalation and killed by cervical dislocation. To obtain 
lung homogenates, 1.5 ml of dispase was installed through the trachea of HBSS 
perfused lungs followed by lung harvest and 40 min incubation in dispase. 
Afterwards, the heart and trachea were removed and lungs were homogenized 
(GentleMACS, MACS Miltenyi Biotech) in DMEM/2.5% HEPES with 0.01% DNase I 
and filtered subsequently through 100 μm and 40 μm nylon filters. Lung 
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homogenates were then centrifuged for 10 min with 500 G at 4°C. To remove red 
blood cells (RBC), cells were resuspended in RBC lysis buffer (0.15 M NH4Cl, 10 mM 
NaHCO3, 1 mM EDTA, pH 7.4) for 90 s. Lysis was stopped by addition of DMEM 
containing 10% FCS and centrifugation with 500 G for 10 min at 4°C. For 
leukocyte/endothelial cell depletion, homogenates were resuspended in DMEM and 
incubated with the appropriate volume of biotinylated rat anti-mouse CD45, 
CD16/32, and CD31 antibodies for 30 min at 37°C. Cells were centrifuged for 10 min 
with 500 G at 4°C and resuspended in DMEM containing biotin-binding magnetic 
beads for 30 min with rotation at room temperature (RT) followed by magnetic 
separation for 15 min at RT. CD45/CD16/32/CD31-negative cells in the flow-through 
were collected and washed once with DMEM and quantified to be used for further 
analysis.   
 
3.2.2. EpiSPC and rMC cell sorting 
Multicolor flow cytometry and cell sorting were performed on a BD FACS AriaTM III 
cell sorter using DIVA software (BD Bioscience). For single cell suspension, cell 
sorting and analysis, cells were pelleted with 500 G, 10 min at 4°C, blocked with 
gammaglobulins (Sandoglobulin) and stained with the corresponding fluorescence-
labeled antibodies for 15 min at 4°C in MACS buffer (PBS, 7.4% EDTA, 0.5% FCS pH 
7.2). Cells were washed once with MACS buffer and centrifuged with 500 G for 5 
min at 4°C, resuspended in 300-500 µl of MACS buffer and filtered into FACS tubes 
for cell analysis and sorting using an 85 µm nozzle.  
 
Unless otherwise specified, rMC and EpiSPC-enriched population were isolated with 
the following antibody cocktail: 
 
Antibody dilution 
CD31 Alexa 488 1:50 
CD45 FITC 1:50 
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3.2.3. EpiSPC and rMC co-culture 
Flow-sorted EpiSPC and rMC were pelleted by centrifugation with 500 G for 5 min at 
4°C. Cells were resuspended in EpiSPC medium (α-MEM, 10% FCS, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 2 mM L-glutamine, 1x Insulin-Transferrin-
Selenium, 0.0002% heparin) and quantified. For co-cultivation, the cell 
concentration was adjusted to 5x103 EpiSPC and 3x104 rMC per 25 µl of EpiSPC 
medium per 12 mm cell culture insert (Millipore). EpiSPC and rMC were mixed and 
diluted with cold growth factor reduced Matrigel® (Corning) at an 1:1 ratio as 
described before85. Cell suspension was gently mixed, avoiding the formation of 
bubbles. For each insert, 90 μl of mixed EpiSPC and rMC in Matrigel were added on 
top of a 0.4 µm filter membrane, placed in a 24-well plate, and incubated for 5 min 
at 37°C for polymerization of Matrigel. 350 μl of EpiSPC medium were added per 
well to obtain an air-liquid interface and cultures were incubated at 37°C with 5% 
CO2 for three weeks to obtain fully formed lung organoids. Medium was changed 
three times per week. Given data is representative for three independent 
experiments. 
 
3.2.3.1. mTmG co-cultures 
For clonal expansion experiments, EpiSPC were isolated from WT and mTmG 
reporter mice, mixed at the ratio of 1:4 and co-cultured with rMC for three weeks. 
For rMC characterization, rMC were isolated from mTmG reporter mice and 
co-cultured with WT EpiSPC for three weeks. 
 
 
 
CD326 (EpCAM) APC/Cy7 1:50 
CD24 PE/Cy7 1:200 
Sca-1 PB 1:50 
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3.2.3.2. SCGB1A1mCherrySFTPCYFP co-cultures 
SCGB1A1+SPC+, SCGB1A1+SFTPC- and SCGB1A1-SFTPC+ cells isolated from an 
EpiSPC-enriched population were co-cultured with rMC at a concentration of 1×103 
or 5×103 cells per insert. In these experiments, cells were isolated based on the 
endogenous mCherry and YFP fluorescence and using the following antibodies: 
 
 
 
 
 
 
 
 
 
3.2.3.3. Co-culture of EpiSPC with PDGFRαGFP rMC 
PDGFRαGFP rMC were co-cultured with EpiSPC isolated from WT or mTmG mice. 
Additionally, rMC were isolated and co-cultured with EpiSPC based on GFP 
expression: PDGFRα negative, low and high.  
 
The following antibodies were used for PDGFRαGFP rMC isolation: 
 
 
 
 
 
 
 
 
 
Antibody dilution 
CD31 PB 1:50 
CD45 HorizonTM V450 1:50 
CD326 (EpCAM) APC/Cy7 1:50 
CD24 PE/Cy7 1:200 
Sca-1 APC 1:50 
Antibody dilution 
CD31 PE 1:50 
CD45 APC/Cy7 1:50 
CD326 (EpCAM) APC/Cy7 1:50 
Sca-1 PB 1:50 
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3.2.3.4. GM-CSF -/- and GM-CSFRβ-/- co-cultures 
Sorting of GM-CSF-/- cells was performed as described before in point 3.2.2. After 
isolation, co-cultures were followed for three weeks and EpiSPC proliferation was 
assessed by measuring of organoid diameters and quantity. 
 
3.3. Experimental protocols   
3.3.1. Organoid IAV infection 
For IAV infection of the organoids, EpiSPC/rMC co-cultures were washed once with 
PBS and infected with mock or 5x106 pfu of WT-SC35M, Cre-SC35MNS1_2A_Cre_2A_NEP174 
(H7N7, mouse-adapted) or A/PR/8/34 (PR8) (H1N1, mouse-adapted) in 600 µl of 
ice-cold PBS for 2 h at RT with gentle agitation. After 30 min incubation at 37°C with 
5% CO2, virus-containing PBS was removed and inserts were washed twice with PBS. 
Inserts were placed in infection medium (α-MEM, 0.2% BSA, 100 U/ml penicillin, 0.1 
mg/ml streptomycin, 1x ITS, 2mM L-glutamine, 0.0002% heparin) and incubated for 
the indicated times. Presented data is representative of three independent 
experiments. 
 
3.3.2. Organoid dissociation 
To assess organoid cell composition and infection, organoids were removed from 
cell culture inserts by addition of ice-cold PBS and rigorous pipetting, collected in 1.5 
ml tubes and centrifuged with 500 G, 10 min at 4°C. Organoids were dissociated by 
incubation with 200 µl dispase for 30 min at 37°C with mild rotation. Digested 
organoids were washed once with 1 ml DMEM and twice with MACS buffer and 
centrifuged with 500 G for 5 min at 4°C. During these steps, organoids were further 
dissociated into single cells by gentle pipetting, stained with antibodies and 
analyzed by flow cytometry. 
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3.3.3. Cell sorting of infected cells 
After digestion of IAV and mock-infected organoids, cells were pelleted with 500 G, 
10 min at 4°C, blocked with gammaglobulins and stained with the corresponding 
fluorophore-labeled antibodies for 15 min at 4°C in MACS buffer. Cells were washed 
once with MACS buffer and centrifuged with 500 G for 5 min at 4°C, stained in 250 
μl of MACS buffer containing the secondary antibody against IAV hemagglutinin 
(HA) for 15 min at 4°C. Cells were washed as stated before, resuspended in 300-500 
μl of MACS buffer and filtered into FACS tubes for cell sorting using an 85 µm nozzle.  
 
The following antibodies were used for cell sorting of infected cells: 
 
 
 
 
 
 
 
 
 
 
3.3.4. Flow cytometry analysis of infected cells 
Multicolor flow cytometry was performed on a BD FACS AriaTM III cell sorter using 
DIVA software. For single cell suspension analysis, cells were pelleted with 500 G, 10 
min at 4°C, blocked with gammaglobulins and surface cell markers were stained 
with the corresponding fluorescence-labeled antibodies for 15 min at 4°C in MACS 
buffer. Cells were washed as stated before and fixed with 100 μl 1% PFA for 10 min 
at 4°C in the dark. For evaluation of nucleoprotein (NP) expression, cells were 
washed and permeabilized with 100 μl 0.2% saponin in PBS for 15 min at 4°C in the 
dark. Cells were washed again and internal markers were stained with the 
Antibody dilution 
CD31 Alexa 488 1:50 
CD45 FITC 1:50 
CD326 (EpCAM) APC/Cy7 1:50 
Podoplanin (PDPN) APC 1:20 
Hemagglutinin (HA) 1:75 
Secondary antibody  
Donkey anti-goat Alexa 647 1:500 
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corresponding fluorescence-labeled antibodies for 30 min at 4°C. Cells were washed 
with MACS buffer containing 0.1% Saponin. At last, cells were resuspended in 300 μl 
of MACS buffer, filtered and transferred to FACS tubes for analysis. Corresponding 
isotype antibodies were used as negative controls. Given data is representative of 
three independent experiments.  
Antibody mix for infected organoids NP analysis: 
 
 
 
 
 
 
 
 
 
3.3.5. Plaque assay 
One day before infection MDCK cells (1×106 per well) were seeded into a 12-well 
plate and cultured at 37°C, 5% CO2. The next day, infection was done in duplicate 
using cell culture supernatants of 48 h post infection (pi) in 250 µl PBS for 1 h at 
37°C. 500 µl of pre-warmed Avicel® overlay medium (MEM, 0.1% BSA, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 0.1% Hepes, 2 µg/ml trypsin (TPCK-treated), 
1.25% Avicel) was added. Plates were incubated at 37°C, 5% CO2 without 
movement. After 48 h Avicel overlay was removed, cells were fixed with 4% PFA in 
PBS for 15 min at RT. Cells were washed twice with PBS and permeabilized with 
0.3% Triton X-100 in PBS for 15 min at RT. Staining for viral proteins was done using 
a polyclonal antibody against Influenza A virus (Abcam) in staining buffer (PBS, 10% 
HS, 0.1% Tween-80) for 1 h at RT. Cells were washed three times with wash buffer 
(PBS, 0.05% Tween-80) and incubated with horseradish peroxidase-conjugated 
secondary antibody (Santa Cruz) for 1 h at RT in the dark. Cells were washed four 
Antibody dilution 
Extracellular  
    CD326 (EpCAM) APC-eF780 1:100 
    CD24 PE/Cy7 1:200 
    Sca-1 PB 1:50 
Intracellular  
    Viral nucleoprotein (NP) FITC 1:20 
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times with wash buffer. NP staining was visualized using TrueBlueTM peroxidase 
substrate for up to 30 min. Cells were washed twice with dH2O to stop the reaction. 
Stained plaques were counted and represented as a mean. Given data is 
representative of three independent experiments.  
 
3.3.6. Morpholino transfection 
Scrambled morpholino (Scra) control (sequence: 5´-CCTCTTACCTCAGTTA 
CAATTTATA-3´) and miR142-3p-specific morpholino (mo142-3p) (sequence: 
5´-TCCATAAAGTAGGAAACACTACACC-3´) (Gene Tools, LLC) were prepared in α-MEM 
with 0.2% FCS at a concentration of 4 µM. At day 6 of culture, mo142-3p or Scra was 
applied to co-cultures overnight for three consecutive nights, followed by 
application for 48 h for days 9 to 11. EpiSPC proliferation was assessed by measuring 
the organoid diameters on the day of treatment and 5 days later (day 11). Then, 
treated organoids were removed from Matrigel, digested and flow-sorted based on 
EpCAM expression. For further experiments, lung organoids were subsequently 
treated every 24 h with mo142-3p or Scra until day 21 of culture. Branching in lung 
organoids was assessed by counting the branching points after 15 days of treatment 
with Scra or mo142-3p using confocal microscopy. Given data is representative of 
three or four independent experiments. 
 
3.3.7. GM-CSF ELISA 
A commercially available ELISA kit (R&D Systems) was used according to the 
manufacturer’s instructions to determine the concentration of GM-CSF in cell 
culture supernatant. Samples were stored at -80°C and used undiluted for ELISA. 
Cytokine abundance was quantified by addition of a luminescent substrate and 
colorimetric detection at 450 nm wavelength in a microplate reader (Bio-Rad). 
GM-CSF concentration was calculated on basis of samples of known concentration 
in a standard curve. Given data is representative of three independent experiments.  
 
Methods 
 
32  
 
3.3.8. Anti-GM-CSF mAb treatment 
From day 2 of co-culture, medium was replaced by EpiSPC medium containing 50 
ng/ml of anti-GM-CSF mAb or isotype control (R&D Systems). EpiSPC proliferation 
was assessed by measuring organoid diameters and quantity on days 6,8, and 11 of 
culture. Treatment continued until day 21. Given data is representative of three 
independent experiments. 
 
3.3.9. Isolation and FACS analysis of TR-Mac  
Bronchoalveolar lavage was collected from the lungs of mTmG adult mice with 
PBS/EDTA. The lavage was centrifuged at 500 G for 5 min at 4°C and cells were 
resuspended in DMEM medium (10% FCS, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 2 mM L-glutamine). Cells were then plated on non-treated petri 
dishes for 1 h with 5% CO2 at 37°C. Medium was removed and adherent cells were 
washed once with PBS. For cell detachment, tissue-resident alveolar macrophages 
(TR-Mac) were treated with Accutase for 20 min with 5% CO2 at 37°C. At last, 
TR-Mac were collected into a Falcon tube using a cell scraper, centrifuged and 
resuspended in medium until further analysis. 
 
For flow cytometry analysis, TR-Mac were pelleted with 500 G, 10 min at 4°C, 
blocked with gammaglobulins and stained with the corresponding 
fluorescence-labeled antibodies for 15 min at 4°C in MACS buffer. Cells were 
washed once with MACS buffer and centrifuged with 500 G for 5 min at 4°C, 
resuspended in 200 μl of MACS buffer and filtered into FACS tubes for cell analysis. 
 
The following antibodies were used for TR-Mac characterization: 
 
Antibody dilution 
Gr1 PE-Cy7 1:100 
CD45 HorizonTM V500 1:100 
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3.3.10. Microinjection of TR-Mac  
On day 14 of culture, microinjection of TR-Mac isolated from mTmG mice into lung 
organoids was performed using an oil-filled microinjection system (CellTram®Vario) 
with 10 µm diameter capillary needle (Eppendorf) and DMIL LED microscope (Leica). 
After microinjection, cultures were kept in the incubator with 5% CO2 at 37°C until 
further analysis. 
 
3.3.11. Microscopy 
3.3.11.1. Immunofluorescence 
Co-cultures were fixed with 4% PFA for 10 min at RT. Cultures were washed with 
buffer (0.2% BSA/PBS), permeabilized with 0.1% triton/PBS for 5 min and blocked in 
5% HS, 2% BSA/PBS for 30 min at RT. For staining, cultures were incubated with 
primary antibodies over night at 4°C, followed by washing and addition of secondary 
antibodies for 2 h at RT. For staining of PDGFRαGFP cultures, cultures were not 
permeabilized. Given data is representative of three independent experiments.  
 
3.3.11.2. LysoTracker, phospholipid and neutral lipid staining 
For staining of lamellar bodies, LysoTracker® Red DND-99 (Thermo Scientific) stock 
solution was diluted in pre-warmed α-MEM according to the manufacturer’s 
instructions. 25 nM LysoTracker was added to co-cultures and incubated for 30-60 
min at 37°C. Similarly, for staining of phospholipids, red phospholipidosis detection 
reagent (Thermo Scientific) was diluted 1:500 in α-MEM and added to EpiSPC/rMC 
co-cultures for 48 h. For staining of neutral lipids, co-cultures were fixed with 4% 
PFA for 15 min, washed twice with PBS and stained with 1x of PBS diluted 
LipidTOX™ red neutral lipid staining solution (Thermo Scientific). After 6 h 
Ly6G APC 1:50 
Siglec-F APC-CY7 1:50 
CD11c FITC 1:20 
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incubation at RT, cultures were co-stained with DAPI and mounted in glass slides for 
imaging. Given data is representative of three independent experiments.   
 
3.3.11.3. β-galactosidase staining 
Organoids were fixed with 4% PFA for 5 min at RT, washed once with PBS and 
incubated with pre-warmed LacZ buffer (5 mM [Fe(CN)6]3−, 5mM [Fe(CN)6]4−, 2 mM 
MgCl2 in PBS) for 10 min at 37°C. LacZ buffer was replaced with staining solution (1 
mg/ml X-Gal in LacZ buffer) and incubated at 37°C until blue staining became visible. 
Stained cultures were rinsed once with PBS and kept in PBS at 4°C for further 
analysis. Given data is representative of three independent experiments. 
 
3.3.11.4. Microscopes  
Micrographies of co-cultures were taken using the EVOSTM FL Auto Imaging System 
(Thermo Scientific). A Leica SP8 confocal microscope was used for confocal imaging 
as indicated in the results section. For live cell imaging of organoid formation, a 
Leica DMI6000 B microscope was used. 
 
3.3.12. Gene expression analysis 
3.3.12.1. RNA isolation 
RNA was isolated from flow-sorted cells and organoid cultures using RNeasy Micro 
Kit or miRNeasy Mini Kit (Qiagen). After cell sorting or organoid dissociation, cells 
were washed once with PBS (500 G, 5 min at 4°C) and lyzed in 350µl RLT buffer. 
Samples were then processed according to the manufacturer’s instructions. RNA 
concentration and purity were analyzed by spectrophotometry (Nanovue Plus, GE 
Healthcare). 
 
3.3.12.2. cDNA synthesis 
cDNA was synthesized using M-MLV reverse transcriptase (Invitrogen) and random 
hexamer primer according to the manufacturer’s instructions using 250 ng of total 
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RNA. For reverse transcription of miR142-3p a stem loop reverse primer was used 
according to the protocol published by Tang and co-workers175. All incubation steps 
were performed in a PeqSTAR thermocycler (Peqlab, Erlangen). 
 
3.3.12.3. Quantitative real-time PCR 
Quantitative PCR was performed in a StepOnePlus™ Real-Time PCR System (Thermo 
Scientific) using SYBR Green (Life Technologies) according to the manufacturer’s 
instructions. The relative gene expression levels were normalized to ribosomal 
protein subunit S-18 (RPS-18) or 5S rRNA and presented as fold change (2ΔΔCt) or 
gene expression relative to day 0, Scra, or mock. Given data are representative of 
three independent experiments. 
 
The following primers were used:  
Rps-18 FP 5’-CCGCCATGTCTCTAGTGATCC-3’ 
 RP 5’-TTGGTGAGGTCGATGTCTGC-3’ 
Ifnβ FP 5’-GTTACACTGCCTTTGCCATCC-3’ 
 RP 5’-GTGGAGTTCATCCAGGAGACG-3’ 
Sftpc FP 5’-GGAGGAAGGGCATGATACTGG-3’ 
 RP 5’-TTCTACCGACCCTGTGGATGC-3’ 
Foxj1 FP 5’-GAGCCAGGCCTCACATTCG-3’ 
 RP 5’-CGCTGGTAACCCAGACTCC-3’ 
Muc5ac FP 5’-AGGACCACTGTATTGCTGGC-3’ 
 RP 5’-TCCAGAACATGTGTTGGTGC-3’ 
Hopx FP 5’-CAACAAGGTCAACAAGCACCC-3’ 
 RP 5’-GCGCTGCTTAAACCATTTCTGC-3’ 
NP FP 5’-ACGAAGGTGGTCCCAAGAGG-3’ 
 RP 5’-GATTTGGCCCGCAGATGCC-3’ 
Sox9 FP 5’-GAAGAACGGACAAGCGGAGG-3’ 
 RP 5’-GATTGCCCAGAGTGCTCGC-3’ 
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Rarb FP 5’-GGTCTCTCATGAAGCTAGCTATTTATCTG-3’ 
 RP 5’-CAGTTCTTATCTCGATGGCAAGTG -3’ 
5S rRNA FP 5’-TCTCGGAAGCTAAGCAGGGTC-3’ 
 RP 5’-AGCCTACAGCACCCGGTATTC-3’ 
miR142-3p FP 5’-ACTCCAGCTGGGTGTAGTGTTTCCTACTT-3’ 
 stem loop reverse 5’-CTCAACTGGTGTCGTGGA 
GTCGGCAATTCAGTTGAGTCCATAAA-3’ 
 universal reverse 5’-TCAACTGGTGTCGTGGAGTCG-3’ 
 
3.3.13. IAV infection in vivo experiment 
WT, GM-CSF-/- and SPC-GM adult mice were infected with 500 pfu of PR8 applied 
intratracheally. After 7 days of infection, mice were anesthetized with isoflurane 
inhalation and killed by cervical dislocation. Lungs were perfused with HBSS 
followed by intratracheal instillation of 1.5 ml 1:1 TissueTek: 2% PFA/PBS mixture. 
Lungs were then harvested, embedded in TissueTek:PBS, frozen in liquid nitrogen 
and stored at -80°C. For immunofluorescence, cryoslices with 5 µm thickness were 
prepared using a Leica CM 1850 UVcryotome. Before staining, slices were air-dried, 
fixed with 4% PFA for 20 min at RT, washed with PBS/0.2% BSA, and permeabilized 
with 0.3% Triton-X-100 for 10 min at RT. Cryoslices were then blocked using 10% HS 
in PBS for 1 h at RT and stained with SFTPC and ki67 antibodies as described in 
section 3.3.11.1. Given data are representative of four independent experiments. 
 
3.4. Statistics 
All data are given as mean ± SEM. Statistical significance between two groups was 
estimated using the unpaired Student’s t test. For comparison of three groups, 
ANOVA and post-hoc Tukey’s test were performed. Calculations were done with 
GraphPad Prism 5 (GraphPad Software, Inc.). A P-value lower than 0.05 was 
considered to be significant. 
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Results 
4. RESULTS 
4.1. 3D co-culture of EpiSPC and rMC results in the formation of bronchioalveolar 
lung organoids 
As previously described, EpiSPC are capable to form organoids in vitro only when 
FGF10 and HGF are present in the culture medium85. rMC are known to be a source 
of such growth factors and promote branching morphogenesis and alveolar 
septation during lung development3,24,176. Therefore, the establishment of a lung 
organoid model combining EpiSPC and rMC to better recapitulate the structural and 
cellular composition of the lung was envisioned. EpiSPC and rMC for 3D cultures 
were isolated from leukocyte/endothelial cell-depleted lung homogenate of adult 
mice by high-speed cell sorting. For this purpose, expression signature for EpiSPC 
(EpCAMhighCD24lowitg6highitg4highCD200+Sca-1+) and rMC (EpCam-Sca-1+) was 
exploited85. After doublet discrimination, EpiSPC and rMC populations were 
FACS-separated based on the surface expression of EpCAMhighCD24lowSca-1+ and 
EpCAM-Sca-1+, respectively (Fig. 4-1). Following cell sorting, purity of EpiSPC and 
rMC was approximately 90% and 98%, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1. EpiSPC and rMC isolation from adult murine lung. Gating strategy for cell 
sorting of EpiSPC and rMC from CD31/CD45-depleted lung homogenate. 
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Flow-sorted EpiSPC and rMC were counted and seeded into Matrigel for 3D 
cultures. Growth and development of lung organoids was monitored over 21 days. 
EpiSPC proliferated in culture forming colonies between day 4 to 6. After 10 to 11 
days in culture, most organoids further increased in size and changed morphology 
from spherical to diverse asymmetrical forms. By day 21, lung organoids 
differentiated into bronchioalveolar lung organoids (BALO) characterized by the 
presence of elongated tubular and multiple saccular structures (Fig. 4-2A and D) 
representing the airway and alveolar in situ morphology, respectively. In addition to 
BALO, two other types of organoids were found with a much lower incidence (~10% 
of total organoids per well). These organotypic structures remarkably resembled 
formerly described bronchiolar organoids134, termed here bronchiolospheres, and 
alveolospheres73. While during early phases of organoid development colonies are 
rather similar, mature bronchiolospheres (Fig. 4-2B) and alveolospheres (Fig. 4-2C) 
did not form defined tubular structures. Notably, bronchiolospheres maintained a 
disorganized arrangement whereas alveolospheres developed later during culture 
and were characterized by a compact saccular conformation.  
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Figure 4-2. Organoid formation during EpiSPC and rMC co-cultivation.  EpiSPC formed 
three distinct lung organoids. Representative images of EpiSPC proliferation and 
differentiation into (A) BALO, (B) bronchiolosphere, and (C) alveolosphere at day 8, 10 and 
21 of culture. Scale bars represent 100 μm. (D) Representative confocal images showing 
tdTomato+ BALO tubular and saccular structures at day 21 of culture. Scale bars represent 
100 (left) and 50 (right) µm. 
 
4.2.  BALO are generated from single EpiSPC  
The term organoid refers to 3D structures derived from a single stem cell population 
capable to differentiate into organ-specific cells types which self-organize to form a 
structure resembling the cellular organization of the organ of origin115,167. To assess 
BALO clonality, flow-sorted EpiSPC from WT and mTmG tdTomato (a red fluorescent 
protein)- expressing mice were mixed at a ratio of 1:4 and co-cultured with rMC. 
Throughout co-cultivation, only WT or tdTomato+ BALO but no mixed phenotypes 
were observed by microscopy (Fig. 4-3A). Further indication for BALO clonality was 
obtained by live cell imaging in which growth and development of WT and 
tdTomato+ BALO were monitored from day 15 to 20 and no mixed phenotypes were 
observed (Fig. 4-3B). Overall, these data confirm the capacity of EpiSPC to expand 
and differentiate into BALO in the presence of rMC. 
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Figure 4-3. BALO clonality. EpiSPC derived from WT or mTmG mice during co-cultivation 
with rMC gave rise to individual BALO. (A) Representative images of day 8 and 21 BALO 
(white dashed line) derived from WT (arrow) or mTmG mice. (B) Live cell imaging-derived 
images of WT (yellow dashed line) and tdTomato+ BALO from day 15 to 20 of culture. Scale 
bars represent 100 μm. 
 
4.3.  EpiSPC giving rise to BALO possess a BASC phenotype 
In relation to seeded EpiSPC, an average ratio of 1:100 BALO developed after 21 
days in culture suggesting that only a small fraction of the sorted EpiSPC population 
had the capacity to proliferate and generate BALO. As described before, BASC are 
stem cells located at the BADJ which can self-renew and differentiate into 
bronchiolar cells and AEC in response to injury (Fig. 1-3). BASC express EpCAM, 
Sca-1, and co-express SFTPC and SCGB1A151, therefore, to investigate if BASC were 
the progenitor cells within the EpiSPC population giving rise to BALO, a 
Scgb1a1mCherrySftpcYFP double-fluorescent reporter mouse line was used. 
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EpiSPC were flow-sorted from lung homogenate of Scgb1a1mCherrySftpcYFP mice 
following the same gating strategy as previously described in figure 4-1 (Figure 
4-4A). Expression of SCGB1A1 and SFTPC within the EpiSPC population was also 
analyzed (Figure 4-4B). Remarkably, only about 5% of the EpiSPC population was 
double-positive for SCGB1A1+SFTPC+. While most cells (95%) were SCGB1A1+SFTPC-, 
SCGB1A1-SFTPC+ cells represented only a minor fraction (<0.5%). Nonetheless, by 
day 21 of co-culture, mCherry+YFP+ BASC-derived BALO accounted for 80% of all 
organoids suggesting that BALO are derived from BASC (Fig. 4-4C). 
Bronchiolospheres were composed solely of SCGB1A1+ cells and accounted for only 
11%, whereas alveolospheres were composed solely of SFTPC+ cells and accounted 
for 9% of all organoids. Of note, the presence of cells with the SCGB1A1+SFTPC+ 
BASC phenotype within the EpiSPC fraction was further confirmed by microscopic 
analysis of freshly-sorted cells after doublet exclusion (Fig. 4-4D). 
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Figure 4-4. Characterization of the sorted EpiSPC population using Scgb1amCherrySftpcYFP 
double-fluorescent reporter mice. SCGB1A1+SFTPC+ EpiSPC differentiated into BALO. (A) 
Gating strategy for cell sorting of EpiSPC from double-fluorescent reporter mice. (B) 
Percentage of SCGB1A1+SFTPC+, SCGB1A1+SFTPC- or SCGB1A1-SFTPC+ cells within the 
EpiSPC population in n=4 different experiments and mean ± SEM is depicted. (C) 
Percentage of SCGB1A1+SFTPC+ BALO, SCGB1A1+SFTPC- bronchiolospheres or SCGB1A1-
SFTPC+ alveolospheres organoids after 21 days in culture in n=4 different experiments and 
mean ± SEM is depicted. (D) Representative images of freshly sorted SCGB1A1+SFTPC+, 
SCGB1A1+SFTPC- or SCGB1A1-SFTPC+ cells. Scale bars represent 25 μm.  
 
To further demonstrate that BASC is the stem cell population responsible for BALO 
formation, EpiSPC were flow-sorted according to single or double expression of 
SCGB1A1 and SFTPC, and developing organoids were followed over time by confocal 
microscopy (Fig. 4-5). In SCGB1A1+SFTPC+ BASC-derived organoids, SCGB1A1+ and 
SFTPC+ cells were uniformly distributed within early-stage BALO with only a small 
fraction of double-positive cells remaining at day 8 of culture. Between days 11 to 
21, cells located within BALO-central branches were SCGB1A1+ whereas the outer 
alveolar-like structures were comprised of SFTPC+ cells indicating the presence of 
club cells and AECII, respectively (Fig. 4-5A). In contrast, culture of SCGB1A1 or 
SFTPC single-positive cells gave rise to bronchiolospheres or alveolospheres, 
respectively (Fig. 4-5B-C). Notably, SCGB1A1+SFTPC- and SCGB1A1-SFTPC+ organoids 
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remained single positive during culture and never gave rise to BALO. These results 
confirmed previous morphological observations on growth and differentiation of 
EpiSPC described in figure 4-2.  
 
Figure 4-5. SCGB1A1 and SFTPC expression in EpiSPC-derived organoids. Only 
double-positive EpiSPC gave rise to BALO. Representative confocal images showing 
endogenous SCGB1A1 and SFTPC expression during (A) BALO, (B) bronchiolosphere, and (C) 
alveolosphere formation derived from EpiSPC sorted based on their expression of 
SCGB1A1+SFTPC+, SCGB1A1+SFTPC- or SCGB1A1-SFTPC+, respectively. Arrowheads indicate 
SCGB1A1+SFTPC+ co-expressing cells. Scale bars represent 100 μm. 
 
Together, the data indicate that a rare SCGB1A1+SFTPC+ BASC population within the 
EpiSPC fraction exhibits high stem cell potential and gives rise to BALO containing 
central SCGB1A1+ tubular and surrounding SFTPC+ saccular structures. Therefore, 
EpiSPC giving rise to BALO henceforth will be defined as BASC. 
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4.4 BALO model 3D morphology and cellular composition of the bronchioalveolar 
compartment 
To characterize BALO with respect to their cellular composition, whole lung 
homogenate from adult mice and freshly sorted BASC and rMC were compared to 
day 21 digested cultures using flow cytometry (Fig. 4-6A-C). After 21 days of culture, 
BALO were comprised of a major EpCAM+ and a minor EpCAM- cell population. 
Remarkably, EpCAM+ cells consisted of cell fractions identical in lineage marker 
expression and in frequency as to the murine adult lung, including a major fraction 
of AECII (94.3±0.2% in BALO and 95±0.1% in lung), low-frequent podoplanin (PDPN)+ 
AECI (5.3±0.6% in BALO and 4.9±0.2% in lung), and EpCAMhighCD24high small airway 
(bronchial) epithelial cells (2.5±1.8% in BALO and 2.2±1% in adult lung). This latter 
fraction contained also 0.2±0.9% EpCAMhighCD24lowSca-1+ EpiSPC in BALO, as 
observed in adult lung 0.5±0.4% (Fig. 4-6B). Moreover, a fraction of the EpCAM-
Sca-1+ rMC population from freshly sorted cells became EpCAM-Sca-1- after 21 days 
in culture suggesting differentiation of sorted rMC during culture (44.5±16% in 
co-cultures and 88.3±2.2% in lung) (Fig. 4-6C). Of note, day 21 co-cultures lack CD45 
and CD31-expressing cells. In addition, freshly sorted rMC and BASC were mixed 
(day 0) and gene expression was compared to cells isolated from complete BALO 
co-cultures on days 10 and 21. In comparison to day 0, cells from day 21 co-cultures 
showed significant upregulation of genes for differentiation markers of the adult 
lung e.g. Hopx and Sftpc for AECI and AECII and Foxj1 and Muc5ac for ciliated and 
goblet cells, respectively (Fig. 4-6D).  
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Figure 4-6. Cell composition comparison between lung homogenate from adult mice, 
freshly sorted BASC/rMC and day 21 BALO cultures. Cells isolated from BALO expressed 
markers of differentiated cell types of the adult lung. (A) Flow cytometry analysis of the 
BASC and rMC purity after cell isolation (day 0). (B-C) Flow cytometry analysis of lung cell 
homogenate from adult mice and day 21 BALO and rMC. (D) Gene expression analysis of 
Hopx, Sftpc, Foxj1, and Muc5ac at day 0, 10 and 21 of culture in n=3 different experiments 
and mean  SEM is depicted (P-value <0.05). 
 
To further confirm cell differentiation in BALO, confocal microscopy using 
fluorescence-labeled markers for airways and alveoli was used (Fig. 4-7A-B). As 
previously shown in figure 4-5 with organoids derived from SCGB1A1+SFTPC+ BASC, 
central tubular structures within BALO were positive for small airway club marker, 
SCGB1A1 and peripheral alveolar structures were positive for the AECII marker, 
SFTPC (Fig. 4-7A). Moreover, BALO were positive for PDPN and β-IV tubulin 
Results 
 
46  
 
representing markers for differentiated alveoli (AECI) and airways (ciliated cells), 
respectively (Fig. 4-7A-B). Notably, recent stereological analysis has shown that the 
mean alveolar diameter of the lung alveoli was calculated to be 45.06 µm ± 1.4 in 9 
week-old (adult) mice177. To compare alveolar morphometry of BALO to mouse 
lungs, the diameter of the alveolar structures in day 21 BALO were quantified and 
the results showed similar values to adult mouse lungs (45.17 µm ± 3.5) (Fig. 4-7C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-7. Epithelial cell differentiation markers and alveolar morphology in BALO. BALO 
possess a proximo-distal specification. Representative confocal images of (A) SCGB1A1+, 
SFTPC+, PDPN+ (arrows), and (B) β-IV tubulin+ cells in day 21 BALO. Scale bars represent 50 
(left) and 25 μm (right). (C) Alveolar diameter in BALO was calculated from n=5 BALO in n=3 
different experiments, and a representative image of alveolar size quantification is 
depicted. Yellow lines indicate 45μm. 
 
Since AECII are a main component in BALO, the long-term functionality with respect 
to surfactant secretion, a factor important to limit surface tension in the lung and a 
component of innate host defense, was investigated. BALO were stained with 
LysoTracker dye, a marker for surfactant-containing lamellar bodies in differentiated 
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AECII, and with LipidTOX for phospholipids as a major component of the pulmonary 
surfactant at day 56 and 21 of culture, respectively. Compared to 
bronchiolospheres, alveolar spaces within BALO were highly positive for both, 
lamellar bodies and phospholipids (Fig. 4-8 A and B). In addition, BALO also stained 
positive for neutral lipids, another component of the surfactant (Fig. 4-8C).  
 
Figure 4-8. Surfactant components in 
BALO. BALO AECII contain lamellar bodies 
and secrete surfactant to the alveolar-like 
spaces. (A) Lamellar bodies staining of day 
56 BALO and bronchiolosphere (dotted 
lines) with LysoTracker. Staining of (B) 
phospholipids and (C) neutral lipids in day 21 BALO and bronchiolospheres (dotted lines) 
with LipidTOX. Scale bars represent 100 μm. 
 
In summary, the BALO in vitro model meets all described criteria referring to 
organoid definition published by Lancaster and Knoblich115. Accordingly, multiple 
lung-specific cell types that resemble the in vivo context were identified in BALO 
including spatially restricted cell lineage commitment with organization into defined 
tubular (bronchial airway) and saccular (alveolar) compartments, and alveolar 
structures containing functional pulmonary surfactant-secreting AECII.   
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4.5 Distinct fibroblast subsets develop from EpCAM-Sca-1+ rMC within BALO 
cultures and are indispensable for BALO growth, branching morphogenesis, 
and cell differentiation  
Crosstalk between epithelial and mesenchymal cells is indispensable for branching 
morphogenesis and cell differentiation during lung development9. Hence, in order 
to assess the relevance of rMC presence during BALO formation, microscopic 
analysis of rMC expressing tdTomato during co-cultivation with BASC was 
performed. By day 8 of culture, only a few rMC directly interacted with the 
developing BALO. However, as culture progressed, rMC incorporated within BALO 
providing a scaffold for the forming BALO (Fig. 4-9). Remarkably, tdTomato+ rMC 
gave rise to multiple fibroblast cell types, including cells containing lipid inclusions 
(data not shown) and spindle-shaped cells by day 21 of culture. These results 
indicate that distinct rMC subpopulations directly interact with epithelial cells 
throughout BALO development. 
 
 
 
 
 
 
Figure 4-9. rMC are required for BALO formation. rMC are indispensable for organoid 
development and give rise to diverse cell types during co-cultivation. Time course images 
of BALO formation during co-cultivation with tdTomato+ rMC reveals structural integration 
of rMC into the developing BALO. Scale bars represent 100 μm.  
 
The high complexity and diversity within the fibroblasts and mesenchymal stem cell 
populations in the lung has been well documented9. Notably, platelet derived 
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growth factor receptor alpha+ (PDGFRα) lung fibroblasts were shown to be crucial 
for alveolarization and realveolarization178. Therefore, to better characterize rMC 
heterogeneity, PDGFRαGFP reporter mice were employed. Through flow cytometry 
analysis, two distinct populations were identified within the sorted CD45-CD31-
EpCAM-Sca-1+ fraction and defined as PDGFRαlow and PDGFRαhigh rMC (Fig. 4-10A). 
Notably, reciprocal expression of Sca-1 and PDGFRα was observed in rMC, 
PDGFRαhigh rMC were Sca-1int while PDGFRαlow rMC were Sca-1high. Sorted rMC 
derived from PDGFRαGFP mice were co-cultured with BASC, and BALO development 
and GFP expression was monitored for 21 days. Comparable with the observations 
made on figure 4-9, from days 8 to 21 of culture, PDGFRαhigh rMC proliferated and 
were increasingly observed within BALO (Fig. 4-10B-C). These data suggest that the 
PDGFRαhigh rMC population is necessary for proper BALO development.  
 
Figure 4-10. PDGFRα expression in the sorted rMC population.  rMC differentially express 
PDGFRα during co-cultivation. (A) Flow cytometry analysis of PDGFRα expression in rMC 
derived from PDGFRαGFP mice lung homogenates. (B) Time course images of BALO 
formation during co-cultivation with rMC derived from PDGFRαGFP mice. Scale bars 
represent 100 μm.  
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To further define the crucial population(s) within the rMC population necessary for 
BALO formation, rMC were sorted according to their differential expression of 
PDGFRα and co-cultured with BASC. Organoid growth and development was 
monitored by microscopy for 21 days (Fig. 4-11). The PDGFRαlow rMC population 
sustained initial colony outgrowth but did not promote organoid formation whereas 
PDGFRαhigh-expressing rMC co-cultivated with BASC failed to support organoid 
formation (Fig. 4-11A-B). However, culture with both PDGFRαhigh and PDGFRαlow 
expressing rMC resulted in complete BALO formation indicating that both 
populations are required for proper organoid growth and development (Fig. 4-11C). 
Of note, due to the reciprocal expression of Sca-1 and PDGFRα in rMC (see Fig. 
4-10A), expression of PDGFRα was dispensable for the rMC gating strategy and Sca-
1 was employed as sole positive marker for rMC isolation (see Fig. 4-1).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-11. BALO development when cultured with different subsets of 
PDGFRα-expressing rMC. Both PDGFRαhigh and PDGFRαlow rMC populations are necessary 
for organoid growth and formation. Representative images of BASC co-cultivation with (A) 
Sca-1highPDGFRαlow, (B) Sca-1intPDGFRαhigh, and (C) Sca-1+PDGFRαlow/high rMC populations. 
Scale bars represent 100 μm. 
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Moreover, WT and PDGFRα-expressing rMC were analyzed by fluorescence 
microscopy. As previously observed, a part of rMC differentiated into lipid 
droplet-containing cells which is a characteristic feature of lipofibroblasts while 
other cells acquired spindle-shape, as typical for myofibroblasts179,180. To assess 
presence of lipofibroblasts and myofibroblasts, LipidTOX and αSMA stainings were 
performed in day 21 co-cultures. LipidTOX+ cells were detected nearby lung 
organoid structures whereas αSMA+ cells supported organoid structure by providing 
a scaffold within BALO (Fig. 4-12A-B). Moreover, several PDGFRαlow rMC were 
LipidTOX+ while a fraction of PDGFRαhigh rMC was αSMA+ which confirmed the 
presence of lipofibroblasts and myofibroblasts, respectively (Fig. 4-12B). In 
accordance, αSMA+PDGFRαhigh myofibroblasts accumulate within BALO structure 
(Fig. 4-12C). 
 
Figure 4-12. Characterization of 
lipofibroblasts and myofibroblasts within 
the rMC population.  Lipofibroblast and 
myofibroblast phenotypes were found in 
day 21 BALO cultures. Representative 
confocal images of BASC co-cultivation 
with (A) WT or (B-C) PDGFRα-expressing rMC stained with αSMA antibody (yellow arrows) 
and/or LipidTOX (red arrows). The right panel in (B) only depicts PDGFR-GFP to 
demonstrate that SMA+ and LipidTOX+ cells are PDGFR high and low, respectively.  
Scale bars for A-B represent 50 (left) and 25 (right) μm. Scale bars for C represent 100 (left) 
and 50 (right) μm. 
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Taken together, when co-cultured with BASC, cells within the rMC heterogeneous 
population are capable to differentiate into at least two cell types including 
lipofibroblasts and myofibroblasts which were shown to be vital for lung organoid 
formation. 
 
4.6 BALO can be supplemented with TR-Mac 
The reported BALO model has so far consisted of epithelial and mesenchymal cells 
but lack other cells present in the lung required for organ functionality. To add 
another layer of cellular complexity to the system, an experimental procedure to 
introduce a tissue-resident myeloid cellular component of the lung was established. 
Tissue-resident alveolar macrophages (TR-Mac) were isolated from the 
bronchoalveolar lavage of tdTomato-expressing reporter mice and microinjected 
into day 14 BALO using injection needles with 10 µm diameter (Fig. 4-13B). Prior to 
microinjection, TR-Mac surface expression signature (CD45+Ly6-G-Gr1-
CD11c+Siglec-F+) was confirmed by FACS (Fig. 4-13A). During BALO formation, 
TR-Mac remained within BALO and showed homing to the alveolar compartment 
(Fig. 4-13C). Moreover, preservation of TR-Mac phenotype was proven by positive 
staining with TR-Mac markers CD206 and Siglec-F 14 days after microinjection (Fig. 
4-13D). Thus, this model offers the possibility to analyze defined TR-Mac gene 
products and AEC/TR-Mac signaling networks in the context of lung development 
and disease. The feasibility of microinjection into BALO may also allow analyzing and 
visualizing interactions of lung epithelial cells with other leukocyte populations 
during development and disease.  
Results 
 
53  
 
 
 
 
 
 
 
 
 
 
Figure 4-13. TR-Mac maintain alveolar identity after incorporation into BALO. BALO can 
be complemented with microinjected TR-Mac. (A) Gating strategy to define TR-Mac from 
bronchoalveolar lavage of adult tdTomato+ mice. (B) Representative images of tdTomato+ 
TR-Mac microinjection into day 14 BALO. (C) Representative images of day 14 BALO 6 h 
after microinjection of tdTomato+ TR-Mac. Scale bar represent 100 μm (left) and 50 μm 
(right). (D) Fluorescence confocal images of CD206, Siglec-F, or isotype stainings 14 days 
after tdTomato+ TR-Mac microinjection at day 28 BALO. Scale bars represent 100 μm (left) 
and 25 μm (right). 
 
4.7 BALO as a model to study developmental questions of the alveolar epithelium 
Having established a functional in vitro model for the murine distal lung, it was 
crucial to assess BALO applicability to study lung generation and regeneration 
processes including developmental aspects of bronchioalveolar formation.  
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Therefore, experiments directed to recapitulate in vivo findings described in the 
literature were performed using the BALO model. Carraro and co-workers have 
recently shown that microRNA 142-3p (miR142-3p) regulates WNT-dependent 
mesenchymal progenitor cell proliferation in the developing mouse lung181. In their 
work, morpholinos, oligos that bind to complementary RNA, were used to inhibit 
miR142-3p activity and maturation in embryonic lung explants. miR142-3p-specific 
morpholino (mo142-3p) not only decreased lung mesenchyme proliferation but also 
reduced lung growth and branching morphogenesis. Based on these observations, 
co-cultures were treated with mo142-3p to evaluate whether miR142-3p effects on 
lung development could be recapitulated in this BALO model. Notably, intermittent 
treatment with mo142-3p at an early culture stage prompted a significant decline in 
stem cell proliferation compared to scrambled morpholino (Scra) (Fig. 4-14A). 
Moreover, gene expression of epithelial and mesenchymal miR142-3p obtained 
from mo142-3p-treated BALO cultures was significantly downregulated in both 
compartments in comparison to Scra-treated cultures confirming miR142-3p loss of 
function (Fig. 4-14B). 
 
Figure 4-14. Effect of miR142-3p inhibition on BASC proliferation. mo142-3p addition to 
co-cultures led to organoid growth reduction. (A) Organoid diameter at day 0 and 5 days 
after treatment with Scra or mo142-3p. Mean ± SEM is depicted (n=3, P-value <0.05). (B) 
Gene expression analysis by qPCR of epithelial and mesenchymal miR142-3p in co-cultures 
after 5 days of treatment with Scra or mo142-3p. Mean ± SEM is depicted (n=3, P-value 
<0.05).   
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It has been previously shown that miR-142-3p controls canonical WNT signaling by 
targeting adenomatosis polyposis coli (APC), a main part of the β-catenin 
destruction complex182. To assess WNT signaling down-regulation in the model, 
BASC from TOPGAL mice were co-cultivated with WT rMC or vice versa, and treated 
with mo142-3p or Scra at day six of culture (Fig. 4-15A-B). TOPGAL mice express 
β-galactosidase controlled by the LEF/TCF-mediated signaling pathway and 
activated β-catenin183. Thus, TOPGAL activation is a direct indicator for active 
canonical WNT signaling in a cell. Before mo142-3p or Scra addition, comparable 
levels of WNT signaling expression were observed in BALO at day 6 of culture (Fig. 
4-15A). Treatment of cultures with mo142-3p over five days resulted in a marked 
decrease in WNT signaling levels in BALO as compared to Scra. Similar observations 
were noted in TOPGAL rMC cultures (Fig. 4-15B). Remarkably, day six 
β-galactosidase+ rMC were detected in clusters scattered throughout the Matrigel 
culture while day 11 β-galactosidase+ rMC were mainly found within BALO, as 
described above.  
 
 
 
 
 
 
 
 
 
 
Figure 4-15. Active β-catenin expression in BASC and rMC after mo142-3p treatment. 
Active canonical WNT signalling was reduced in mo142-3p-treated cultures. Representative 
images of β-galactosidase staining in (A) TOPGAL BASC co-cultivated with WT rMC and (B) 
WT BASC co-cultivated with TOPGAL rMC at day 0 and 5 (arrows) after treatment with Scra 
or mo142-3p. Scale bars represent 100 μm. 
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Lastly, BALO formation was examined after 15 days of mo142-3p or Scra application. 
Not only were mo142-3p-treated BALO considerably smaller than Scra-treated BALO 
but also displayed impaired branching morphogenesis shown by the decreased 
number of branching points in mo142-3p-treated BALO. These data indicate that 
miR142-3p loss of function in BALO recapitulates the phenotype found in embryonic 
lung explants, as described in Carraro et al., 2014181(Fig. 4-16A and B). 
 
Figure 4-16. BALO formation after prolonged mo142-3p addition. Loss of miR142-3p 
caused a major defect in branching morphogenesis in BALO. (A) Representative images of 
bright field and LysoTracker staining of co-cultures at day 15 after treatment with Scra or 
mo142-3p. Scale bars represent 100 μm. (B) Number of branching points observed in BALO 
after 15 days of treatment by Scra or mo142-3p. Mean ± SEM is depicted (n=4 BALO, n=3 
experiments P-value <0.05).   
 
Altogether, miR142-3p positive regulation of canonical WNT signaling and its impact 
on lung growth and branching morphogenesis was confirmed in the BALO system, 
but these experiments also revealed that gene knockdown strategies can be 
efficiently applied to that system. These results indicate that the in vitro BALO 
model represents a functional tool to address cell-specific developmental questions, 
especially referring to epithelial-mesenchymal crosstalk during lung development. 
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4.8 Use of BALO model to study the effect of the soluble growth factor, GM-CSF, 
in BASC proliferation and differentiation 
The BALO system was also employed to test if GM-CSF, a well-known differentiation 
factor for myeloid cells, was involved in lung epithelial stem cell proliferation and 
differentiation. In this regard, published and unpublished data acquired in our 
laboratory184 demonstrated that GM-CSF expressed by the alveolar epithelium 
increases survival after IAV infection. To first evaluate the impact of GM-CSF on the 
AECII population in vivo, immunofluorescence of SFTPC and ki67 in mock and 
IAV-infected WT, GM-CSF-/-, and SPC-GM lung sections was performed (Fig. 4-17A-B). 
Of note, SPC-GM mice have a GM-CSF-/- background but overexpress GM-CSF only in 
SFTPC+ cells. 7 days after IAV infection, the number of AECII in infected GM-CSF-/- 
lungs was considerably decreased in comparison with both WT and SPC-GM mice 
(Fig. 4-17A). In accordance, percentage of ki67+ cells was significantly reduced in 
infected GM-CSF-deficient mice compared to WT and SPC-GM mice (Fig. 4-17B). 
These data confirmed previous results indicating that the presence of GM-CSF in the 
alveolar epithelium is crucial for cell proliferation and restoration of the AECII pool 
after viral infection and suggest that GM-CSF may also mediate proliferation of 
epithelial progenitor cell subsets of the distal lung. 
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Figure 4-17. Effect of GM-CSF on AECII numbers and proliferation upon IAV infection. 
Presence or absence of GM-CSF has a significant influence on AECII pool and proliferation 7 
days pi. Representative images and quantification of (A) SFTPC+ and (B) ki67+ cells in mock 
and IAV-infected WT, GM-CSF-/-, and SPC-GM lung sections 7 days pi. Mean ± SEM is 
depicted (n=4 experiments P-value <0.05).   
 
In this line, gene expression of important transcription factors involed in distal lung 
specification, Sex determining region Y-box 9 (Sox9)185 and retinoic acid receptor beta 
(Rarb)186, were downregulated in BASC isolated from GM-CSF-/- in comparison with 
WT BASC (Fig. 4-18A). Based on these data, the in vitro system was exploited to test 
if GM-CSF was involved in BALO formation. Thus, BASC and rMC derived from 
GM-CSF-/- and WT mice were co-cultivated and organoid growth was evaluated at 
day 6 and 11 of culture (Fig. 4-18B). Strikingly, BALO from GM-CSF-/--derived BASC 
were significantly smaller compared to WT cultures. Furthermore, BALO in GM-CSF-
/-co-cultures did not develop tubular and saccular structures (Fig. 4-18C). These data 
suggest that GM-CSF is not only important for BASC proliferation but also for lung 
specification during BALO development. Notably, endogenous GM-CSF release in 
WT BALO starts at day 6 of culture and peaks at day 11, coinciding with the 
beginning of organoid differentiation into BALO (Fig. 4-18D).  
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Figure 4-18. BASC proliferation and differentiation in GM-CSF-/- co-cultures. 
GM-CSF-deficient BASC show reduced proliferation and are not able to form BALO. (A) 
Gene expression analysis of Sox9 and Rarb in WT and GM-CSF-/- BASC by qPCR (n=3, P-value 
<0.05). (B) Organoid diameter in WT and GM-CSF-/- cultures at day 6 and 11. Red arrow 
indicates a small organoid. (C) Representative brightfield images of WT and GM-CSF-/- co-
cultures at day 21. Scale bars represent 100 μm. (D) Time course of GM-CSF release in WT 
and GM-CSF-/- co-cultures by ELISA. Mean  SEM is depicted (n=3, P-value <0.05).  
 
To further examine the relevance of GM-CSF in BASC proliferation and BALO 
formation, GM-CSF neutralizing antibodies (Ab) or isotype control were added to 
WT co-cultures.  Once again, BASC proliferation was evaluated at day 6 and 11 of 
culture (Fig. 4-19A). Although a similar effect on BASC proliferation was observed, 
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organoid growth reduction was only significant at day 11 of culture suggesting that 
the antibody does not fully neutralize GM-CSF. Nonetheless, as in GM-CSF-/- 
co-cultures, BALO formation was greatly reduced in anti-GM-CSF Ab treated 
cultures in comparison with isotype-treated cultures (Fig. 4-19B). 
 
 
Figure 4-19. BASC proliferation and differentiation after GM-CSF Ab treatment. BASC 
treated with GM-CSF Ab are less proliferative and form fewer BALO. (A) Organoid diameter 
in isotype- and GM-CSF Ab-treated cultures at day 6 and 11. Mean  SEM is depicted (n=3, 
P-value <0.05). (B) Percentage of Isotype- and GM-CSF Ab-treated BALO per well and 
representative images of whole-well brightfield at day 21 of culture. Mean  SEM is 
depicted (n=4, P-value <0.05).  
 
The GM-CSF receptor is a heterodimer composed of a ligand-binding subunit alpha 
(GM-CSFRα) and a beta subunit which mediates signal transduction (GM-CSFRβ). 
Hence, to further evaluate GM-CSF signalling pathway, BASC and rMC derived from 
GM-CSFRβ-/- and WT mice were co-cultivated. Reduced BASC growth was found in 
day 11 GM-CSFRβ-/- cultures when compared to WT (Fig. 4-20A). Interestingly, in 
GM-CSFRβ-/- day 21 cultures, BASC failed to form BALO with characteristic distal 
specification as verified by lack of distal tip saccular structures (Fig. 4-20B). In 
concordance, low numbers of differentiated AECII were found in GM-CSFRβ-/- BALO 
by confocal microscopy (Fig. 4-20C). 
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Figure 4-20. BASC proliferation 
and differentiation in GM-CSF 
Rβ-/- co-cultures. GM-CSF 
Rβ -deficient BASC proliferate 
less and form defective BALO. (A) 
Organoid diameter in WT and 
GM-CSFRβ-/- cultures at day 6 and 
11 of culture. Mean  SEM is 
depicted (n=3, P-value <0.05). (B) 
Representative brightfield images 
of WT and GM-CSFRβ-/- co-
cultures at day 21. Scale bars 
represent 100 μm. (C) 
Representative confocal images 
of LysoTracker staining in 
GM-CSFRβ-/- co-cultures at day 21 
of culture. Scale bars represent 
100 μm. 
 
In conclusion, the BALO in vitro model shows that GM-CSF is indispensable for BASC 
proliferation and differentiation into AECII and will now be further used to 
determine whether GM-CSF/GM-CSFR regenerative signaling pathway can drive 
lung tissue repair upon lung injury caused by pathogens such as influenza virus. The 
data also demonstrate that the BALO model is useful to study the role of growth 
factors on epithelial cell proliferation and survival, and specification during lung 
development.  
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4.9 BALO support IAV replication and can be used to model lung infection 
The applicability of the BALO system for disease modeling was next tested in an 
influenza infection model, using a highly pathogenic H7N7 and a seasonal H1N1 
strain. To directly visualize infected epithelial cells, a recently generated Influenza A 
reporter virus expressing Cre recombinase (SC35M-Cre) (H7N7)154 was used.  
Identification of IAV-infected cells on a single-cell basis was achieved by using 
SC35M-Cre in combination with BALO derived from a reporter mouse expressing 
membrane-targeted tdTomato (mT) after Cre recombination. BALO were observed 
from 24 to 48 h pi to visualize cell infection, viral spread and virus-induced cell loss. 
BALO were infected by IAV as shown through microscopy. Moreover, viral spread 
was observed between 24 and 48 h pi, indicating that BALO support viral 
replication. Release of infectious influenza A virions from BALO was confirmed by 
plaque assay of cell culture supernatant at 48 h pi (Fig. 4-21B). In parallel, significant 
loss of tissue areas in BALO was observed at 48 h, which had been infected at 24 h, 
reflecting loss of cells observed in IAV-induced lung injury in vivo187 (Fig. 4-21A).  
 
H1N1 viral proteins, hemagglutinin (HA) and nucleoprotein (NP), are indispensable 
for successful viral infection and replication. For instance, HA binds on the surface of 
the host cell through its α-sialic acid receptor and mediates virus entry whereas NP 
is essential for viral replication as part of the ribonucleoprotein complex176. 
Therefore, to further demonstrate successful BALO infection in terms of generation 
of viral proteins in infected epithelial cells, gene expression analysis of NP was 
performed in flow-sorted infected and non-infected cells. Respectively, EpCAM+HA+ 
and EpCAM+HA- cells were analyzed by qPCR, where, as expected, NP expression 
was detected only in the infected epithelial cell population (Fig. 4-21C). Additionally, 
the proportion of infected EpCAM+ epithelial cells showing productive viral 
replication was determined by FACS analysis of intracellular NP expression. On 
average, 8% of BALO epithelial cells were infected (Fig. 4-21D). The EpCAM- 
mesenchymal cell population in BALO was not infected by IAV as previously 
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observed in vivo85 (data not shown). To define cellular responses to infection in 
BALO, interferon beta (Ifnβ) expression in non- and IAV-infected BALO cells was 
analyzed by qPCR. A significant upregulation of Ifnβ was observed in IAV-infected 
EpCam+HA+ BALO cells, indicating that BALO epithelium not only supports IAV 
infection and spread, but is also functional with respect to mounting an antiviral 
response upon IAV infection and can therefore be used for viral infection disease 
modeling (Fig. 4-21E).  
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Figure 4-21. Analysis of IAV infection in BALO. BALO support IAV infection of alveolar 
epithelial cells. (A) Representative images of BALO infection by Cre-SC35M IAV (red) after 
24 and 48 h. Cell loss was observed 48 h pi (white arrows). Scale bars represent 100 μm. (B) 
Plaque assay of mock and infected co-culture supernatants 48 h pi. Mean  SEM is 
depicted (n=3). (C) Gene expression analysis of NP in mock and infected EpCAM+ cells by 
qPCR. Mean  SEM is depicted (n=3). (D) Percentage of NP in mock and infected EpCAM+ 
cells by FACS. Mean  SEM is depicted (n=3).  (E) Gene expression analysis of Ifnβ in 
non-infected and infected EpCAM+ cells by qPCR. Mean  SEM is depicted (n=3, P-value 
<0.05).  
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Discussion 
5 DISCUSSION 
 
This thesis describes the establishment of a robust protocol for isolation and 3D 
culture of murine BASC and rMC giving rise to complete BALO, and possessing 
distinct proximo-distal specification with tubular and saccular lung structures after 
21 days of culture. The system is easily amenable for various applications for organ 
development and disease modeling. The stem cell of origin contained in the 
previously-defined EpCAMhighitg(α6β4)+CD24low EpiSPC population85 that generates 
BALO was characterized in detail. Cells with a “BASC” signature134(Sca-
1+SFTPC+SCGB1A1+) were capable of multilineage differentiation which seems a 
prerequisite for successful BALO formation. 3D culture data indicate that a high 
BALO purity (>80%) can be achieved when both Sca-1 and CD24 markers are 
included to define the BASC population and a strict gating strategy (exclusion of 
alveolosphere- and bronchiolosphere-forming progenitor cells) is applied. 
Compared to other similar models, this approach represents a substantial 
improvement in organoid structural homogeneity. For instance, only ~20% of the 
forming organoids in previously reported models possess cell markers representing 
both bronchiolar and alveolar compartments61,134. These findings will be relevant for 
numerous future applications (e.g. drug screening), as single BASC could be easily 
deposited by automated single-cell sorting and generate a complete BALO per cell 
culture well.  
 
Most of the established models for human lung development and disease are based 
on iPSC differentiated in 2D cultures, therefore lacking a robust 3D structure 
including branched airways and distal alveoli48,135,141,171,172,188–191. Recently, iPSC-
derived human lung organoids were demonstrated to form airway-like structures, 
but maintain a relatively high number of undifferentiated epithelial progenitor cells 
and low numbers of differentiated bronchial and alveolar cells, particularly 
AECI135,192,193. In addition, generation of lung-like structures from human pluripotent 
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stem cells is relatively time-consuming and requires several months until final 
differentiation stages are reached (~180 days)193. In contrast, investigation of the 
cellular composition of BALO using qPCR, immunofluorescence and FACS provided 
evidence that all major cell types of the conducting airways as well as alveoli are 
present. In particular, FACS analysis of single-cell suspensions derived from BALO 
reproduced the cellular composition of adult mouse lungs, and AECII within the 
alveolar BALO compartment were capable of surfactant secretion. To my 
knowledge, the BASC-derived organoid model is the only one that offers this level of 
complexity and allows direct observation of stem cell proliferation and organ 
development.  
 
The phenotype and spatial organization of co-cultured mesenchymal cells emerged 
as another important aspect of a successful lung organoid system. During 
development, mesenchyme-derived growth factors drive epithelial proliferation, 
differentiation, and branching morphogenesis194. Previous studies revealed that 
lipofibroblasts are located at the base of the alveoli and express low levels of 
PDGFRα, whereas non–lipid-containing myofibroblasts are PDGFRαhigh and reside at 
the alveolar entry ring during development195,196. A previous study in which AECII 
were co-cultured with PDGFRα+ cells revealed that these cells are necessary for 
alveolosphere formation73. Accordingly, CD31-EpCAM-Sca-1+ rMC proved to be 
indispensable for proper BALO formation. Using rMC isolated from PDGFRα reporter 
mice, a PDGFRα fraction of sorted rMC was shown to represent progenitor cells for 
lipofibroblast and myofibroblast phenotypes. αSMA+PDGFRαhigh myofibroblasts 
were detected inside the organoid structures and seemed to provide a scaffold for 
tube formation. However, BASC cultured with myofibroblast precursors alone did 
not show any organoid formation. In contrast, rMC-derived LipidTOX+PDGFRαlow 
lipofibroblasts supported BASC proliferation in the early organoid but did not 
support branching morphogenesis. These data indicate that both PDGFRαhigh and 
PDGFRαlow mesenchymal cell subsets are indispensable components of the stem cell 
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niche and fulfill distinct tasks during BALO formation in absence of endothelial 
cells134. Emergence of distinct myofibroblast and lipofibroblast phenotypes from 
PDGFRαhigh and PDGFRαlow rMC within the developing BALO will enable researchers 
to study epithelial-mesenchymal cross-talk mechanisms and the role of these 
subsets within the niche during organogenesis, injury and repair197.  
 
Another important component of the lung stem cell niche are TR-Mac. Macrophage 
precursors seed the organ as early as E10.5 in different waves and significantly 
contribute to lung development, branching morphogenesis, tissue regeneration and 
remodeling198–201. Establishment of a reliable microinjection protocol enabled us to 
introduce these cells into the alveolar BALO compartment to study and visualize 
these processes. It has been suggested recently that different subsets of 
macrophages might exert different roles for branching, alveolarization, and repair 
after injury202. Vice versa, it seems likely that the developing or repairing epithelium 
provides signals important for programming of macrophages into distinct 
phenotypes. It has been difficult to address the molecular cross-talk between 
immune cells and lung epithelia and to visualize such processes at single-cell 
resolution, particularly in developing embryonic lungs. The BALO model will 
facilitate future mechanistic studies in this field, including the role of different 
myeloid cell populations. Despite the evident advantages of BALO complemented 
with myeloid cells, the in vitro model lacks an endothelial compartment. Endothelial 
cells co-develop with the lung epithelium and it would be of great benefit to study 
endothelial/epithelial cross-talk in vitro or to model lung diseases confined to this 
compartment. Although, CD31+ endothelial cells from adult lung were found to 
drive organoid development from BASC, a proper spatially organized endo-epithelial 
network never developed in such studies134. The question remains whether better-
defined endothelial progenitor cells such as cells derived from multi-potent 
cardiopulmonary mesoderm progenitors203 will be helpful to increase the cellular 
complexity of the BALO model.  
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Current CRISPR/Cas9 protocols mostly rely on 2D growth of cells combined with 
single-cell cloning of respective mutant cells, which has hampered the generation of 
loss of function or gene corrected murine and human lung organoids192. Therefore, 
a knock-down strategy was applied in growing BALO. miR142-3p, a miRNA known to 
inhibit the canonical WNT β-catenin pathway, was suppressed by addition of 
morpholino oligos. This approach faithfully recapitulated developmental defects in 
BALO including reduced growth and impaired branching morphogenesis that were 
previously observed in embryonic lung explants treated with mo142-3p181. In sum, 
knock-down of target genes at different stages of BALO development is a powerful 
tool to dissect the function of individual genes without damaging the organoid and 
without the need for organoid dissociation204.  
 
As previously demonstrated, bacterial and viral lung infection stimulate the release 
of GM-CSF in vivo which acts as a growth factor driving cell-mediated repair 
mechanisms by inducing AECII proliferation and restoring the alveolar epithelial 
barrier after injury113,205. These observations were further confirmed in vivo by IAV 
infection of WT and transgenic mice. In these experiments, AECII pool and cell 
proliferation was markedly decreased in the absence of GM-CSF. Next, in vitro 
experiments with the newly established BALO model using BASC and rMC derived 
from GM-CSF- and GM-CSFRβ-deficient mice were performed. Interestingly, the 
model revealed that GM-CSF is indispensable for cell proliferation and 
alveologenesis of BALO. In concordance, gene expression of Sox9 and Rarβ, 
transcription factors involved in stem cell differentiation and proliferation, was 
downregulated in BASC isolated from GM-CSF-deficient mice. Laresgoiti and 
colleagues showed that STAT3 signalling pathway drives alveolar differentiation of 
Sox9+ distal tip progenitor cells during lung development206. In this line, previous 
data showed that GM-CSF can signal through JAK/STAT pathway in hematopoietic 
cells207 suggesting that STAT3 could represent a downstream target for GM-CSF 
signalling pathway during development and tissue repair in the lung. Notably, 
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recent single cell RNA sequencing data indicates that GM-CSF gene expression is 
highly upregulated in the epithelium and in SFTPC and SCGB1A1-expressing cells 
during murine lung development at E16.5 and E18.5, respectively208. Therefore, 
GM-CSF-dependent developmental programs might be re-activated during repair 
after IAV-induced injury. The BALO in vitro system will be of high relevance to 
further elucidate the underlying molecular pathways and cellular cross-talk 
mechanisms by which GM-CSF induces alveolar repair from stem cell pools of the 
distal lung in our future work.  
 
In a recent study, human lung organoids derived for hPSC were infected with 
respiratory syncytial virus. After 48 h of infection, apoptosis and shedding of 
infected cells occurred, resembling to some extent morphological aspects observed 
in humans during viral infection206. However, in this model, organoids developed 
slowly (~170 days), forming only early alveolar structures, and are unlikely to be 
suitable to study infections affecting the bronchioalveolar compartment. 
Accordingly, BALO epithelium infected by different strains of IAV, supports viral 
replication and spread, and is capable of initiating an antiviral immune response. 
Moreover, compared to in vivo infection models, the BALO model facilitates live cell 
imaging of infected cells and - regarding further applications - drug library screens 
for antiviral drugs could be performed146. In this context, an example of the use of 
organoid models to study bacterial infection was given by Bartfeld and colleagues. 
This work showed successful infection of mouse and human gastric organoids by 
direct microinjection of Helicobacter pylori into the organoids lumen209. Besides the 
study of viral infections, BALO are well applicable to model other diseases that 
affect the distal lung, such as bacterial pneumonia caused by Streptococcus 
pneumonia or Pseudomonas aeruginosa210. 
 
Altogether, the in vitro model presented here generates predominantly BALO, that 
recapitulate the cellular and structural complexity of the bronchioalveolar lung 
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compartment. Similar models are scarce and observed organoids only possessed a 
minor degree of bronchiolar and alveolar specification. Moreover, BALO system 
reproduces lung developmental processes, permits viral infection and replication, 
and supports homing and persistence of injected tissue-resident myeloid cells such 
as TR-Mac. Thereby, this model opens several new avenues to study lung 
development, infection, and regenerative processes in vitro. 
 
In the future, the BALO model might be used to: 1) visualize tissue regeneration 
after injury induced by infection or other insults at high resolution (up to single-cell 
level) and over time, and 2) pinpoint the role of cells of mesenchymal, epithelial and 
myeloid origin in these processes. The possibility to supplement the alveolar space 
of BALO with different tissue-resident or bone marrow-derived leukocyte 
populations of interest adds a further level of complexity that was not addressed in 
previously described models. The employment of BASC, rMC and/or leukocytes 
derived from transgenic mice with gain- or loss of function of defined genes, or from 
reporter mice, will enable characterization of cell-specific functions of individual of 
genes. Such feature is currently difficult to achieve using human lung organoid 
models derived from tissue-endogenous stem cells or iPSC. In this regard, deep 
sequencing of the murine BASC is currently employed to derive marker genes for 
identification of a comparable endogenous stem cell type in human lung tissue for 
development of human lung organoids with a high cellular and structural 
complexity.  
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Summary 
6 SUMMARY 
 
Organoid model systems derived from mouse and human stem cells have recently 
evolved as a powerful tool to study development and disease. A murine 3D 
bronchioalveolar lung organoid model was established based on FACS-sorting of a 
newly defined population of bronchioalveolar stem cells. Upon co-culture with 
subsets of lung mesenchymal cells, which model the stem cell niche of the 
developing lung, these stem cells underwent clonal expansion, followed by 
branching morphogenesis and self-organization into complete lung organoids, while 
retaining their tissue-of-origin commitment and their potential to differentiate into 
functional cells. Of note, organoids closely reproduced the 3D structure and cellular 
composition of the bronchioalveolar compartment of the lung. In addition, the 3D 
bronchioalveolar organoid structure allowed seeding of tissue-resident 
macrophages into the alveolar compartment, providing the possibility to study the 
contribution of the resident myeloid cell pool to developmental and regeneration 
processes within the alveolar microenvironment. Moreover, lung organoids derived 
from gene-deficient mice and selective inhibitor experiments revealed that the 
GM-CSF/GM-CSFR axis was necessary for BALO growth, survival, and alveolarization. 
Organoids were suitable for FACS-based single cell analyses, and for genetic 
manipulation as demonstrated by successful knockdown of genes involved in lung 
development and targeting miR142-3p/β-catenin signaling. Finally, organoids could 
be used to model lung infection, as demonstrated by use of reporter-tagged 
influenza viruses in conjunction with live cell imaging, gene expression and 
functional analyses. In summary, this is the first organoid model recapitulating the 
3D structure and cellular composition of the bronchioalveolar lung compartment, 
opening up new avenues to model lung development, infection, and regeneration 
processes. 
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7 ZUSAMMENFASSUNG  
 
In den letzten Jahren wurden zunehmend Organoid-Modelle beschrieben, die von 
murinen oder humanen Stammzellen ausgehen und Organe ex vivo simulieren. In 
der vorliegenden Arbeit wurde ein solches 3D Modellsystem für die murine Lunge 
etabliert, basierend auf FACS-Sortierung einer neu definierten Population 
bronchoalveolärer Stammzellen. Um die Stammzellnische einer sich entwickelnden 
Lunge zu rekapitulieren, wurden diese Zellen mit einer definierten Population 
mesenchymaler Zellen der Lunge ko-kultiviert.  Unter diesen Bedingungen waren 
einzelne Lungenstammzellen in der Lage, klonal zu expandieren, und durch 
Selbstorganisation ein jeweils vollständiges Organoid der Lunge zu bilden. Von 
Bedeutung ist in diesem Zusammenhang, dass diese Organoide sowohl die drei 
dimensionale Struktur als auch die zelluläre Zusammensetzung des 
bronchoalveolären Kompartiments der Lunge vollständig widerspiegeln. Darüber 
hinaus gelang es, sich entwickelnde Alveolen der Organoide mit 
Alveolarmakrophagen zu besiedeln. Dies eröffnet die Möglichkeit, den Einfluss von 
Gewebe-ständigen myeloiden Zellen auf Entwicklungs- und Regenerationsprozesse 
in der Alveole zu untersuchen. Es besteht zudem die Möglichkeit, Organoide zu 
generieren, die von Gen-defizienten Zellen abstammen. Mit Hilfe solcher Organoide 
oder mittels Applikation von spezifischen Inhibitoren während der 
Organoid-entwicklung konnte gezeigt werden, dass die GM-CSF/GM-CSFR Achse für 
das Wachstum und die proximo-distale Spezifizierung von Lungenorganoiden von 
zentraler Bedeutung ist. Darüber hinaus konnten wir zeigen, dass Organoide sowohl 
das Ausschalten definierter Gene im epithelialen und mesenchymalen 
Kompartiment erlauben, als auch die Durchführung von Infektionsexperimenten mit 
Influenza Virus, was mittels Lebendzell-Imaging, Analyse der viralen Replikation, und 
der zellulären Immunantwort gezeigt werden konnte. Insgesamt beschreibt die 
vorliegende Arbeit das erste 3D-Modellsystem für die murine Lunge, das die 
Struktur und zelluläre Zusammensetzung des bronchioalveolären Kompartiments 
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vollständig rekapituliert. Dadurch eröffnen sich vielfältige Möglichkeiten, zukünftig 
Entwicklungs-, Regenerations- sowie Infektionsprozesse in der Lunge hochauflösend 
und auf Einzelzell-Ebene zu analysieren. 
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9.2 Materials 
9.2.1. Chemicals and consumables  
Chemical/consumable Manufacturer 
Avicel AMC Biopolymers, Brüssel (BEL) 
Biotin-binder magnetic beads Life Technologies, Carlsbad (USA) 
BSA  Sigma-Aldrich, Taufkirchen (GER) 
Cell culture flasks 75cm2 Greiner, Nürtingen (GER) 
Cell culture inserts 12mm Merck Millipore, Darmstadt (GER) 
Cell culture plates, single- and multi-
well 
Greiner, Nürtingen (GER) 
Cell nylon filters 20µM Merck Millipore, Darmstadt (GER) 
Cell scraper, 18cm handle Greiner, Nürtingen (GER) 
Cell strainer filters 40, 70 and 100µm   BD Biosciences, San Jose (USA) 
DAPI Life Technologies, Carlsbad (USA) 
DMEM Gibco BRL, Karlsruhe (GER) 
dNTP's  Thermo Scientific, Waltham (USA) 
EDTA  Roth, Karlsruhe (GER) 
Ethanol Sigma-Aldrich, Taufkirchen (GER) 
FCS  Life Technologies, Carlsbad (USA) 
Fluoromount-G SouthernBiotech, Birmingham (USA) 
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GentleMACS C tubes Miltenyi Biotec, Bergisch Gladbach (GER) 
HBSS Gibco BRL, Karlsruhe (GER) 
HEPES Merck Millipore, Darmstadt (GER) 
HS  Sigma-Aldrich, Taufkirchen (GER) 
Insulin-Transferrin-Selenium Biozym Scientific, Hessisch Oldendorf (GER) 
L-Glutamine [200mM] Gibco BRL, Karlsruhe (GER) 
LipidTOX™ red neutral lipid stain Thermo Scientific, Waltham (USA) 
LipidTOX™ red phospholipidosis 
detection reagent 
Thermo Scientific, Waltham (USA) 
LysoTracker® Red DND-99 Thermo Scientific, Waltham (USA) 
Magnesium sulfate Sigma-Aldrich, Taufkirchen (GER) 
Matrigel matrix Corning Life Sciences, Tewksbury (USA) 
Parafilm American National, Greenwich (USA) 
Paraformaldehyde  Merck, Darmstadt (GER) 
PBS Life Technologies, Carlsbad (USA) 
PBS++ (containing MgCl) PAN-Biotech, Aidenbach (GER) 
Penicillin/Streptomycin  
[5000 U/ml] 
Gibco BRL, Karlsruhe (GER) 
Pipettes 10 μm BioMedical Instruments, Zöllnitz (GER) 
Polystyrene round-bottom tubes 5ml BD Biosciences, San Jose (USA) 
Polystyrene tubes, 15ml and 50ml  Greiner, Nürtingen (GER) 
Potassium chloride Sigma-Aldrich, Taufkirchen (GER) 
Reaction tubes 0.5ml and 1.5ml Eppendorf, Hamburg (GER) 
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Sandoglobulin Novartis, Basel (CH) 
Saponin Merck Millipore, Darmstadt (GER) 
SYBR Green I Life Technologies, Carlsbad (USA) 
Syringe 1ml, 10ml and 20ml  Braun, Melsungen (GER) 
TissueTek Sakura, Alphen aan den Rijn (NL) 
Triton-X-100 Roth, Karlsruhe (GER) 
Tween 80 Sigma-Aldrich, Taufkirchen (GER) 
αMEM Gibco BRL, Karlsruhe (GER) 
 
9.2.2. Enzymes and morpholino 
Enzyme/morpholino Manufacturer 
Accutase Corning Life Sciences, Tewksbury (USA) 
Dispase Corning Life Sciences, Tewksbury (USA) 
DNase I Serva, Heidelberg (GER) 
miR142-3p Scra /morpholino Gene Tools, LLC, Philomath (USA) 
MLV-RT Life Technologies, Carlsbad (USA) 
Trypsin-EDTA Merck Millipore, Darmstadt (GER) 
Trypsin-TPCK Worthington Biochemical, Lakewood (USA) 
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Biotinylated rat anti-mouse CD16/32 BD Biosciences, San Jose (USA) 
Biotinylated rat anti-mouse CD31 BD Biosciences, San Jose (USA) 
Biotinylated rat anti-mouse CD45 BD Biosciences, San Jose (USA) 
CD11c FITC (clone: N418) BioLegend, San Diego (USA) 
CD206 (clone:MR5D3) Thermo Scientific, Waltham (USA) 
CD206 Alexa Fluor® 488 (clone: MMR) BioLegend, San Diego (USA) 
CD24 PE/CY7 (clone: M1/69) BioLegend, San Diego (USA) 
CD31 Alexa Flour 488 (clone 390) BioLegend, San Diego (USA) 
CD31 PB (clone 390) BioLegend, San Diego (USA) 
CD31 PE (clone 390) BioLegend, San Diego (USA) 
CD326 APC/Cy7 (clone G8.8) BioLegend, San Diego (USA) 
CD326 APC-eF780 (clone G8.8) Thermo Scientific, Waltham (USA) 
CD45 APC/Cy7 (clone 30-F11) BioLegend, San Diego (USA) 
CD45 FITC (clone 30-F11) BD Biosciences, San Jose (USA) 
CD45 HorizonTM V450 (clone 30-F11) BD Biosciences, San Jose (USA) 
CD45 HorizonTM V500 (clone: 30-F11) BD Biosciences, San Jose (USA) 
Gr1 PE-Cy7 (clone: RB68C5) BioLegend, San Diego (USA) 
IgG Alexa Fluor 488, mouse Merck Millipore, Darmstadt (GER) 
Influenza A Virus, polyclonal  
(clone ab20841) 
Abcam, Cambridge (UK) 
Isotype control IgG1 (clone: CT6) Abcam, Cambridge (UK) 
Isotype control IgG2a (clone RTK2758) BioLegend, San Diego (USA) 
Isotype control Syrian hamster IgG BioLegend, San Diego (USA) 
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(clone SHG-1) 
Isotype-matched normal goat IgG Santa Cruz Biotechnology, Dallas (USA) 
Ki67 (clone: SolA15) Thermo Scientific, Waltham (USA) 
Ly6G APC (clone: 1A8) BioLegend, San Diego (USA) 
mAb anti-GM-CSF R&D Systems, Inc. Minneapolis (USA) 
NP FITC (clone: 431) Abcam, Cambridge (UK) 
PDPN APC (clone: 8.1.1.) BioLegend, San Diego (USA) 
Sca-1 APC (Clone: D7) BioLegend, San Diego (USA) 
Sca-1 PB (clone: D7) BioLegend, San Diego (USA) 
SCGB1A1 (clone T-18) Santa Cruz Biotechnology, Dallas (USA) 
Secondary goat Alexa Flour 647 Life Technologies, Carlsbad (USA) 
Secondary goat Alexa Fluor 488 Life Technologies, Carlsbad (USA) 
Secondary mouse Alexa Fluor 488 Life Technologies, Carlsbad (USA) 
Secondary rabbit Alexa Fluor 555 Life Technologies, Carlsbad (USA) 
SFTPC (polyclonal) Merck Millipore, Darmstadt (GER) 
Siglec-F APC-CY7 (clone: E50-2440)  BD Biosciences, San Jose (USA) 
Siglec-F eFluor 660 (clone: 1RNM44N) Thermo Scientific, Waltham (USA) 
αSMA APC (clone: 1A4) R&D Systems, Inc. Minneapolis (USA) 
αSMA FITC (clone: 1A4) Sigma-Aldrich, Taufkirchen (GER) 
β-IVtubulin (clone: ONS.1A6) Abcam, Cambridge (UK) 
 
9.2.4. ELISA  Kit 
ELISA kit Manufacturer 
Supplement 
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mouse GM-CSF,  
detection limit 7 pg/ml 
R&D Systems, Minneapolis (USA) 
 
 
9.3  List of Abbreviations  
Abbreviations 
°C Celsius 
ALDH1 Aldehyde dehydrogenase isoform 1 
APC Allophycocyanin 
approx. approximately 
BMP Bone morphogenetic protein 
BrdU Bromodeoxyuridine 
BSA Bovine serum albumin 
CD Cluster of differentiation 
cDNA Complementary DNA 
CreER Cre recombinase  
CRISPR Clustered regularly interspaced short palindromic repeats 
CyP450-2F2 Cytochrome P450 2F2, CYP2F2 
DAPI 4′,6-Diamidin-2-phenylindol 
dH2O Deionized water 
DMEM Dulbecco’s modified Eagle’s medium 
DNA Desoxyribonucleic Acid 
EDTA Ethylendinitrilotetraacetic acid 
EGF Epidermal growth factor 
ELISA Enzyme Linked Immunosorbent Assay 
EpCAM Epithelial cell adhesion molecule  
FACS Fluorescence activated cell sorting, flow cytometry 
FCS Fetal calf serum 
Fe(CN)6 Ferricyanide 
FGF Fibroblast growth factor 
FGF10 Fibroblast growth factor 10 
FGFR2 Fibroblast growth factor receptor 2 
FITC Fluorescein isothiocyanate 
Foxj1 Forkhead transcription factor 
FP Forward primer 
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G G-force 
g Grams 
GFP Green fluorescent protein 
h Hours 
HBSS Hank's buffered salt solution 
Hoxp Homeobox only protein 1 
HS Horse serum 
ICAM-1 Intercellular cell adhesion molecule-1  
ID2 DNA-binding protein inhibitor 
IL6 Interleukin 6 
Itgβ4 Integrin beta 4 
l Liter 
LEF/TCF Lymphoid enhancer binding factor 1/transcription factor 3 
Lrg6 leucine rich repeat containing G protein-coupled receptor 6  
m Milli 
M Molar 
m2 Square meter 
mAb Murine antibody 
MCDK Madin darbey canine kidney 
MEM Minimal essential medium 
MgCl2 Magnesium chloride 
min Minute 
miRNA Micro ribonucleic acid 
M-MLV Moloney Murine Leukemia Virus 
mRNA Messenger RNA 
n Nano 
NaHCO3 Sodium bicarbonate 
NFATc1 Nuclear factor of activated T cell c1  
NH4Cl Ammonium chloride 
NKX2.1 NK2 homeobox 1 
PB Pacific blue 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PE Phycoerythrin 
PFA Paraformaldehyde 
pfu Plaque forming units 
PI Propidium iodide 
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PR8 Influenza virus A/Puerto Rico/8/34 (H1N1) 
qPCR Quantitative real time polymerase chain reaction 
RNA Ribonucleic acid 
RP Reverse primer 
rpm Revolutions per minute 
s Seconds 
Sca-1 Stem cell antigen-1  
SEM Standard error of the mean 
SO2 Sulfur dioxide 
SOX2 Sex determining region Y-box 2 
SOX9 Sex determining region Y-box 9 
SP Surfactant protein 
STAT3 Signal transducer and activator of transcription 3 
TGFβ Transforming growth factor beta 
TPCK Tosyl phenylalanyl chloromethyl ketone 
U Unit 
YFP Yellow fluorescent protein 
α-MEM Alpha minimal essential medium 
ΔCt Delta Ct 
μ Micro 
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